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Abstract 
 
 
In ageing, sub-populations of nerve growth factor (NGF)-responsive neurons are 
susceptible to neurodegeneration.  Whereas aged sympathetic neurons lose their 
survival dependence on NGF, the NGF precursor, proNGF, has been found to be 
neurotoxic in these cells and this is mediated by p75-neurotrophin receptor (p75NTR) 
and sortilin.  However, the intracellular pathway and mechanisms involved 
downstream require further investigation. 
 
As developing sympathetic neurons are NGF-dependent for survival, apoptosis has 
been observed in neonatal superior cervical ganglion (SCG), following NGF 
withdrawal, which is facilitated by p75NTR but attenuated by c-Jun N-terminal kinase 
(JNK) inhibition.  The p75 neurotrophin receptor-interacting protein (NRAGE) has 
also been implicated in p75NTR-mediated cell death in NGF-responsive neurons.  
While plenty of research has focused on sympathetic neurons in development, this 
study sought to examine the effect of JNK and NRAGE inhibition in cultured SCG 
neurons and glia from aged and young adult mice.    
 
Through the use of pan-JNK inhibitors and AEG3482, which indirectly inhibits JNK 
via HSP90, the survival of young adult and aged NGF-treated cultured sympathetic 
neurons was found to be unaffected, but the formation of neurites and glial processes 
was restricted.  Furthermore, using isoform-specific JNK inhibitors, results were 
consistent with JNK3 having a major role in this process.  The survival and neurite 
outgrowth of NGF-treated cultured aged SCG neurons, subjected to siRNA 
knockdown of NRAGE, were both unaffected.   
 
Interestingly, both AEG3482 and NRAGE siRNA rescued the proNGF-mediated 
killing of aged SCG neurons.  In addition, similar to NGF-treated cells, proNGF-
mediated neurite outgrowth of aged SCG neurons was restricted during JNK 
inhibition but not following NRAGE knockdown in cell culture.  In conclusion, while 
NRAGE is involved in proNGF-mediated neurotoxicity, JNK is required for both the 
proNGF-mediated cell death, and neuritogenesis, of SCG neurons and glia from aged 
mice and these findings have implications for therapeutic intervention.   
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1.1 Introduction 
 
Ageing involves the accumulation of deleterious changes in cells and tissues over 
time, which increases the risk of disease and death.  While the average life expectancy 
has improved, the consequence of an ageing global population is that dementia and 
other neurodegenerative diseases are fast becoming a major health problem - the 
knock on effect resulting in increased staff numbers for diagnosis and treatment, but 
also the huge challenges placed on families, both psychologically and financially.  
Normal ageing is a challenge to every living organism and what drives the process is 
still incompletely understood. 
 
There is extensive variation in ageing and, in humans, differences can be determined 
by nutrition, lifestyle, environment and genetic predisposition (Busse 1987).  
Phenotypically, the most noticeable changes in neurological function are movement 
disorders.  Among the elderly, poor posture and rigidity of joints can lead to gait 
abnormality in acute cases (Rubino 1993).  The senses are also affected with frequent 
reports of visual impairment and severe hearing loss (Schneider et al., 2011).  In the 
brain, the delay of central processing times and gathering of new information results 
in memory loss and other cognitive dysfunctions (Drag and Bieliauskas 2010), while 
additional changes in the body include a decline in renal function (Zhou et al., 2008) 
and respiratory performance (Janssens et al., 1999), besides an increase in systolic 
blood pressure (Tobin and Snyder 1984).  Another characteristic of ageing is the 
atrophy of tissues and organs (Maynard et al., 2015); muscle deterioration is prevalent 
(Mitchell et al., 2012; Walston 2012) and can severely impact bodily functions.   
 
Growing old is inevitable but ways and means of preserving and lengthening the 
quality of life are much desired.  To fully address the issues, it is essential to 
understand the basis of ageing-associated decline at the molecular, functional and 
organismal levels.  Central to this is the loss of irreplaceable cells.  Biochemical events 
that promote cell death are initiated when cells fail to respond adaptively to age-
related increases in oxidative, metabolic or ionic stress, resulting in an excessive 
collection of damaged proteins, DNA and membranes.  While active regulation is 
enforced to combat cell atrophy, the breakdown or failure of this process increases the 
chance of degeneration, thus highlighting the importance of survival mechanisms in 
aged cells.  To complicate matters, cells in adult life are much more diverse than in 
early development, with extensive crosstalk between signalling pathways, making it 
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considerably more difficult to dissect the molecular components involved in these 
pathways. 
 
In the nervous system, cells of all regions are at risk of degeneration; however, there is 
substantial variation in the rate of decline and the primary locations for damage.  
Essentially, physical and molecular characteristics, functional properties and location 
can all determine the fate of neurons and their axons (Morrison et al., 1998).  Larger 
neurons with myelinated axons that extend relatively long distances, from one region 
of the nervous system to another, are generally more vulnerable e.g. from peripheral 
neurons to their targets or from central neurons to peripheral targets.  High-energy 
requirement, reliance on axonal transport for trophic support, a large cell surface area 
exposing cells to toxins, and impaired signal transduction are all contributing factors 
to this increased susceptibility (Schmidt et al., 1990; Cleveland and Rothstein 2001; 
Sieradzan and Mann 2001; Cookson 2005; Moore et al., 2005). 
 
While the central nervous system (CNS) struggles to repair itself after injury, the 
peripheral nervous system (PNS) is well-equipped to regenerate and re-innervate 
neuronal networks (Aguayo et al., 1991), although this process slows with ageing.  
Survival in the PNS is then dependent on how effective the recovery operations are in 
these less functional systems (Verdu and Navarro 1995; Kerezoudi and Thomas 1999; 
Verdu et al., 2000). 
 
A key regulator of survival, growth and repair is neurotrophic signalling.  While 
neurotrophins are implicated in the age-dependent cell death of neurons (Jansen et 
al., 2007; Al-Shawi et al., 2008), they also assist with nerve regeneration (Lindsay 1988; 
Andrews and Cowen 1994b; Gavazzi 1995; Lykissas et al., 2007; Ma et al., 2013), and 
are used therapeutically in neurodegenerative conditions (Isaacson et al., 1990; Apfel 
1999; Siegel and Chauhan 2000; Ross 2004; Aloe et al., 2012). The complexity of the 
signalling pathway is an important component of neural plasticity, which involves 
the modification of neural pathways, and is prompted by changes in behaviour, 
environment and neural processes, or as a result of injury.  This is evident at all stages 
of life, whereby certain characteristic expressions, i.e. the localisation and availability 
of proteins and receptors, are altered to suit the ever-changing environment.   
 
For instance, mature neurons undergo continual adaptation in response to 
physiological demands that are quite different from those in early stages.  During 
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embryogenesis, the formation of neuronal networks is crucial, with the number of 
developing neurons being calibrated to establish an optimally wired nervous system 
(Oppenheim 1991).  As a result, the cell-death pathway is at liberty to remove any 
unwanted cells, often in large numbers.  An important part of this process is to 
establish a retrograde flow of neurotrophins, from the target cell into the nerve 
terminal and up the axon to the cell body (Ginty and Segal 2002).  Neurons that are 
unable to manage this transportation are subjected to degeneration and removed 
from the system.  This provides a ‘survival of the fittest’ type scenario whereby the 
end result is a matched network of neurons and their target cells (Davies 2003; Buss et 
al., 2006).  Once the retrograde flow of neurotrophins is established, it must proceed 
for the entire lifetime of the neuron to maintain a functional differentiated state 
(Barde 1989).  As the role of mature cells is to execute vital neuronal functions, the 
neuronal status shifts from apoptotic vulnerability to survival.   
 
Although the importance of neurotrophins is well documented, knowledge about the 
mechanisms and pathways involved in ageing require further attention.  It is clear 
that aged neurons become less responsive to mature neurotrophins (Uchida and 
Tomonaga 1987; Cowen et al., 1996; Orike et al., 2001b).  However, while aged 
neurons are not dependent on these factors for survival, they still require mature 
neurotrophins for neurite outgrowth (Orike et al., 2001a; Orike et al., 2001b).  More 
importantly, reports in the last 15 years have identified a role for pro-neurotrophins 
in regulating survival in ageing (Al-Shawi et al., 2008), in response to injury 
(Harrington et al., 2004; Arnett et al., 2007) and disease (Fahnestock et al., 2004). 
 
This study aims to further characterise the different components of these survival 
pathways, but also to observe their role during neuronal repair in a sub-population of 
aged neurotrophic-responsive neurons in the PNS. 
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1.2 Peripheral Vulnerability – the sympathetic nervous system 
 
The interactions between peripheral sympathetic neurons and their targets have been 
a major focus for understanding specific mechanisms underlying neuronal atrophy in 
aged organisms, and molecular events involved in neuronal survival, axon growth, 
and dendrite arborisation (Schmidt et al., 1990; Cowen and Gavazzi 1998).  The 
sympathetic system is part of the autonomic division, which controls motor outputs 
of the PNS.  Autonomic ganglia innervate practically all body organs and regulate 
involuntary functions e.g. heart beat, blood pressure, digestion, glandular secretions 
and smooth muscle movements. 
 
Sympathetic ganglia receive preganglionic inputs from nerve fibres emerging from 
the thoraco-lumbar regions of the spinal cord and consist of two major groups: 
paravertebral ganglia (e.g. superior cervical ganglia (SCG)), which are arranged as a 
chain along the spinal column, and prevertebral ganglia (e.g. celiac ganglia), located 
near large blood vessels in the abdomen.  The various types of neurons in 
sympathetic ganglia have been thoroughly characterised (McLachlan 1995; Ribeiro et 
al., 2004; Li and Horn 2006) 
 
Atrophy is common in the sympathetic innervation of numerous peripheral targets in 
ageing (Schmidt et al., 1990), and degeneration has been observed in SCG axons 
associated with the cerebral blood vessels (CV) (Cowen and Thrasivoulou 1990; 
Andrews et al., 1994), pineal gland (Kuchel et al., 1999), and the submandibular gland 
(Andrews et al., 1996).  Further still is the selective vulnerability of specific groups of 
neurons, as not all axonal projections from the SCG show atrophy e.g. the 
sympathetic innervation of aged iris is not significantly affected and SCG iris-
projecting neurons undergo continued growth throughout ageing (Santer 1991; 
Andrews et al., 1996).   
 
Of course atrophy is not just restricted to projections from the SCG, and is observed in 
other sympathetic ganglia, both cervical (Bruzzone et al., 2003) and celiac (Bellinger et 
al., 1992).  However, for the purpose of this study, SCG will remain the primary focus.  
Previous studies of SCG neuron, glial cell morphology and function have been 
investigated in vivo (Hedger and Webber 1976) and in vitro (Tropea et al., 1988).  Age-
related changes have also been previously described (Roivainen and Koistinaho 1996). 
 
 
Introduction 
 
  	
 18 
1.3 Neurotrophic signalling 
 
The first neurotrophin to be identified was nerve growth factor (NGF).  Discovered by 
Rita Levi-Montalcini and Stanley Cohen in the 1950s, NGF was established as a target-
derived trophic agent in the PNS (Levi-Montalcini and Angeletti 1968; Thoenen et al., 
1971), and a promoter of neuronal survival, particularly in peripheral sympathetic 
ganglia (Levi-Montalcini 1987).  In developing sympathetic neurons, NGF was shown 
to influence size (Snider 1988), axonal arborisation (Saffran and Crutcher 1990), 
neurotransmitter synthesis (Thoenen et al., 1971) and preganglionic innervation 
(Purves and Nja 1976).  Trophic effects were later observed in the CNS (Seiler and 
Schwab 1984), mostly promoting survival and preserving the phenotype of 
cholinergic neurons (Batchelor et al., 1989; Ebendal 1989; Schweitzer 1989; Sofroniew 
et al., 2001).  Other well-recognised members of the neurotrophin family are brain-
derived neurotrophic factor (BDNF) (Barde et al., 1982),  neurotrophin-3 (NT-3) 
(Maisonpierre et al., 1990) and neurotrophin-4/5 (NT-4/5) (Berkemeier et al., 1991; 
Ibanez 1995).  Their roles in axonal growth and regeneration (Lykissas et al., 2007) 
and neuronal survival (Barde 1994; Lu et al., 2005) have been reviewed.  
Synthesis of neurotrophins principally takes place in peripheral tissues or target 
neurons that are in contact with axons of neurotrophin-sensitive neurons, usually at 
extensive distances from the cell body.  In the periphery, the tissue sources of 
neurotrophins are typically non-neuronal cells such as muscle and glands, whereas in 
the CNS, primary synthesis occurs in neurons (Thoenen 1995).   
 
To deliver trophic effects in the PNS, neurotrophins bind to receptor complexes on 
nerve endings, which are internalised and retrogradely transported, from distal axons 
to neuronal cell bodies.  The internalised ligand-receptor complex, is incorporated 
into a signalling endosome and transported along microtubules, using dynein as a 
motor protein (Zweifel et al., 2005), transmitting signals to mediate survival, growth 
and gene expression.  The retrograde signalling of NGF was first observed by Ian 
Hendry in SCG targets of the iris (Hendry et al., 1974).  Studies have since shown that 
the initial phases of axonal outgrowth from peripheral ganglia and extension along 
intermediate targets are NGF-independent (Fagan et al., 1996; Glebova and Ginty 
2004; Wickramasinghe et al., 2008), and target-derived NGF is critical for axonal 
extension and arborisation only after the axons have reached their final destinations.  
  
 
 
Introduction 
 
  	
 19 
Mature NGF (mNGF) is translated from a single coding exon, and is synthesised as a 
larger pro-form (proNGF) of ~27-34kDa, which is cleaved by furin or other pro-
protein convertases in the endoplasmic reticulum (ER) and Golgi to produce the C-
terminal mature NGF (mNGF) form of 12-13kDa (Suter et al., 1991; Seidah et al., 1996; 
Lee et al., 2001).  In vivo, NGF swiftly associates to form a non-covalent dimer of 
26.5kDa (Bothwell and Shooter 1977; Narhi et al., 1993).  These and higher molecular 
weight glycosylated NGF precursors have been identified within rodents, both in vitro 
and in vivo (Berger and Shooter 1977; Dicou et al., 1986; Edwards et al., 1988; 
Lakshmanan et al., 1988; Bresnahan et al., 1990; Dicou 1992; Seidah et al., 1996; 
Reinshagen et al., 2000), and are highly homologous to human NGF (Ullrich et al., 
1983).  
 
While NGF is produced and transported from peripheral targets and non-neuronal 
cells, there is a basal level of production within sympathetic neurons.  Hasan et al., 
(2003) reported that NGF mRNA is expressed in nearly half of the neuronal SCG 
population at embryonic day 17, rising to over 90% in the early postnatal period, 
before receding in adult neurons.  Further studies in neonatal neurons, using 
metabolic labelling and immunoprecipitation of NGF-immunoreactive proteins, 
found no detection of mNGF.  This was combined with the detection of high 
molecular weight NGF isoforms in neonatal ganglion homogenates, suggesting that 
proNGF is predominantly secreted at this stage and an autocrine loop may exist.  
 
Following synthesis in the ER, pro-neurotrophins undergo folding and sorting into 
the constitutive (vesicles spontaneously fuse with the plasma membrane to release 
their protein contents into the extracellular space) or regulated secretory pathway 
(extracellular signals trigger the fusion of vesicles) before transportation to the correct 
subcellular compartment.  A large number of non-neuronal cells, such as smooth 
muscle cells, fibroblasts and glia, may not express molecular components of the 
regulated secretory pathway and, therefore, secrete neurotrophins only constitutively.  
In neurons, although regulated secretion is prevalent, the bulk of proNGF is secreted 
constitutively (Lu et al., 2005). 
 
An important role for the pro-domain of proNGF is to ensure correct folding, 
processing and secretion of mNGF (Suter et al., 1991; Rattenholl et al., 2001), including 
sorting into constitutive or regulatory secretory pathways.  There are three dibasic 
processing sites in the pro-domain which are targeted for cleavage in the trans-Golgi 
 
 
Introduction 
 
  	
 20 
network by furins or other pro-protein convertases (Greene et al., 1968; Edwards et 
al., 1988; Seidah et al., 1996).  Proteolysis may also occur extracellularly via plasmins 
or matrix metalloproteases (MMPs) (Leone et al., 2005; Paggi et al., 2006; De Stefano et 
al., 2007).  
Detailed discussions of the neurotrophin family, including the structure and 
molecular evolution have been published (Barde 1994).  Pleiotropic actions of each of 
the four mammalian neurotrophins are mediated through selective binding to one or 
more of their cognate receptor tyrosine kinases, members of the tropomyosin-related 
kinase (Trk) family (Fig 1.1).  NT-3 binds to all three Trk receptors (Lamballe et al., 
1991; Squinto et al., 1991; Ip et al., 1993), while BDNF and NT-4/5 preferentially bind 
to TrkB (Klein et al., 1991b; Squinto et al., 1991).  In sympathetic systems, practically 
all neurons require NGF and preferred receptor, TrkA, for survival, axon growth and 
target innervation (Levi-Montalcini 1987; Edwards et al., 1989; Kaplan et al., 1991; 
Klein et al., 1991a; Smeyne et al., 1994; Hassankhani et al., 1995; Seidah et al., 1996; 
Glebova and Ginty 2004; Kuruvilla et al., 2004). 
 
 
  
 
Figure 1.1: Neurotrophins and their corresponding receptors 
 
The family of neurotrophins display selective binding to three Trk receptors: NGF:TrkA, 
BDNF and NT-4:TrkB, NT-3:TrkC. Image Reference, (Skaper 2012)  
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For the purpose of this study, any further background will concentrate on 
NGF/proNGF-mediated signalling pathways and mechanisms.  For activation of 
intrinsic pathways, mature NGF simultaneously engages two TrkA receptors, 
resulting in receptor dimerisation and trans-phosphorylation (Ibanez et al., 1993).  To 
enhance activation, the widely expressed p75 neurotrophin receptor (p75NTR), a 
member of the tumor necrosis factor (TNF) receptor superfamily, collaborates with 
TrkA to form a high affinity neurotrophin complex (Berg et al., 1991; Hempstead et 
al., 1991; Esposito et al., 2001; Barker 2004). 
 
While p75NTR can modulate NGF/TrkA trophic signalling (Verdi et al., 1994; Brennan 
et al., 1999; Barker 2004; Kuruvilla et al., 2004), Trk-independent p75NTR signalling 
(Majdan et al., 2001) initiates cell death in developing sympathetic neurons.  This has 
also been demonstrated in SCG cultures (Estus et al., 1994; Ham et al., 1995) and in 
vivo (Brennan et al., 1999).  The latter study further illustrates that while a p75NTR-/- 
knockout model rescues cells during development, it
 
does not alter mature 
sympathetic neuron numbers in adult mice.  It was later verified that p75NTR levels 
decrease in adult neurons (Cowen et al., 2003) suggesting that p75NTR is 
developmentally regulated, as discussed later (1.3.1). 
 
Previous reports indicate that NGF binding to TrkA overrides the p75NTR-mediated 
death signal (Yoon et al., 1998; Brennan et al., 1999; Friedman 2000), however, some 
evidence proposes that the complex association between NGF and the p75NTR/TrkA 
heterodimer may actually result in either cell survival or cell death, as reviewed by 
Friedman and Greene (1999); Ceni et al., (2010).  Either way, it is clear that the 
activation of p75NTR-dependent signalling is regulated by the associated co-receptor 
e.g. TrkA and ligand e.g. NGF (Dechant and Barde 2002; Hempstead 2002; Roux and 
Barker 2002; Teng and Hempstead 2004). 
 
Despite NGF being assigned a primary role as a trophic factor, it was also shown to 
influence p75NTR-mediated cell death during the early development of retinal neurons 
(Frade et al., 1996), motoneurons (Sedel et al., 1999); and non-neuronal lineages such 
as oligodendrocytes (Casaccia-Bonnefil et al., 1996) and Schwann cells (Soilu-
Hanninen et al., 1999).  However, it was later postulated that this could be the work of 
the NGF precursor, proNGF (Kaplan and Miller 1997; Jansen et al., 2007).  Confusion 
surrounding the converse actions that pro- and mature neurotrophins have on cell 
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survival originated when Lee et al., (2001) discovered that a mutated form of proNGF, 
resistant to cleavage, promoted cell death in a rat pheochromocytoma cell line (PC12 
cells) and dissociated neonatal SCG neurons.  Further studies confirmed the death-
promoting activity of proNGF in various cell types during early development in 
culture, including oligodendrocytes (Beattie et al., 2002), corticospinal neurons 
(Harrington et al., 2004), photoreceptors (Srinivasan et al., 2004) and basal forebrain 
cholinergic neurons (BFCN) of the CNS (Volosin et al., 2006). 
 
The death response is initiated by complex formation of proNGF with p75NTR and 
sortilin, a member of the Vps10p domain receptor family (Nykjaer et al., 2004; Volosin 
et al., 2006).  Sortilin also binds to other proteins such as neurotensin, sphingolipid 
activator protein (SAP), and lipoprotein lipase (LpL), and has been implicated in the 
correct intracellular trafficking of these polypeptides to and from the Golgi apparatus 
(Petersen et al., 1997; Mazella et al., 1998; Munck Petersen et al., 1999; Nielsen et al., 
1999; Lefrancois et al., 2003).  Not exclusively associated with proNGF, sortilin also 
interacts with the BDNF pro-domain and mediates efficient intracellular targeting of 
proBDNF to the regulatory secretory pathway in neurosecretory and neuronal cells 
(Chen et al., 2005).   
However, in order to elicit cell death, it is believed that sortilin interacts with p75NTR 
at the cell surface (Nykjaer et al., 2004).  An associating factor of sortilin, NRH2, has 
been identified to act as a trafficking switch to prevent lysosomal sortilin degradation 
and redistribution of sortilin to the membrane to promote p75NTR/sortilin complex 
formation in response to pro-neurotrophins (Kim and Hempstead 2009).  
 
Despite evidence of death-promoting activities, there have also been reports of 
proNGF (mutated, cleavage resistant forms) acting neurotrophically in neonatal SCG 
cultures and PC12 cells (Fahnestock et al., 2004; Clewes et al., 2008; Masoudi et al., 
2009).  While some studies indicate that proNGF-induced neurotrophic signalling is 
mediated by TrkA and ERK1/2, it was later discovered that siRNA knockdown of 
TrkA reduced mNGF- but not cleavage-resistant proNGF-dependent neurite 
outgrowth of postnatal SCG neurons in culture.  Furthermore, p75NTR was implicated 
in the process of proNGF-dependent neurite outgrowth (Howard et al., 2013).   It has 
been suggested that TrkA-dependent neurotrophic effects of proNGF are not due to a 
direct interaction but require p75NTR-mediated endocytosis and cleavage to mature 
NGF by furins, as demonstrated in HEK293T cells (Boutilier et al., 2008).  Peri-somatic 
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glia have also been implicated in sortilin and p75NTR dependent cleavage of proNGF 
to mNGF, which subsequently induces neurite outgrowth via TrkA in adult mouse 
DRG neurons (Kalous et al., 2012).  However, in the Howard et al., (2013) study, 
which uses compartmental cultures, proNGF-induced neurite outgrowth is observed 
in postnatal mouse SCG neurons, even in the absence of glial support.   
 
Altogether, the availability of pro-protein convertases e.g furin, proteases e.g MMP-7, 
plasmins, or surrounding glia for cleavage of proNGF may help to determine the final 
signalling outcome, in addition to the availability of relevant receptors and 
downstream effectors.  Protein binding affinities can also be a governing factor.  
ProNGF possesses a high affinity for p75NTR (Lee et al., 2001; Nykjaer et al., 2004) and 
preferentially binds p75NTR over TrkA (Lee et al., 2001), which may explain why 
selective binding of p75NTR, along with the availability of sortilin, leads to apoptotic 
death of cells that express both TrkA and p75NTR. 
 
Another important consideration to make when assessing data is that several proNGF 
studies have extracted information from diverse cell types, including developing 
sympathetic, sensory and central neurons, as well as cell lines.  Not only are there 
variations in cell receptor expression across cell types, but changes in physiological 
functions and growth patterns may also contribute to differing proNGF signalling 
responses.  Furthermore, studies have been conducted with the use of various 
mutated, cleavage resistant proNGF (see proNGF section 3.3.1), as well as wild type 
proNGF, something that must be taken into account when evaluating research. 
 
 
1.3.1 Neurotrophic signalling in ageing 
 
While neurodegeneration of ageing sympathetic systems was originally considered to 
be associated with reduced neurotrophic target support (Cowen et al., 2003), it was 
later suggested that the unprocessed pro-neurotrophin peptides could facilitate this 
process (Al-Shawi et al., 2008). 
Several studies had previously demonstrated proNGF neurotoxicity during early 
development or in vitro, (Nykjaer et al., 2004; Pedraza et al., 2005; Volosin et al., 2006). 
However, in 2008, Al-Shawi et al. showed that subpopulations of central and 
peripheral neurons derived from old rodents were killed by proNGF, and observed a 
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significant reduction in proNGF-mediated neuronal loss when using Neurotensin, a 
physiological ligand for sortilin, on aged brain slices (Al-Shawi et al., 2008).  This 
complemented studies that revealed an increase in sympathetic neuron survival in 
sortilin-deficient aged animals, greater than a year old (Jansen et al., 2007).  In the 
Jansen et al., (2007) study, sortilin expression was shown to increase the affinity of 
pro-neurotrophins to p75NTR by 100-fold.  Furthermore, data illustrated an up-
regulation of sortilin in vulnerable populations of basal forebrain cholinergic neurons 
(BFCN) and SCG neurons in aged rodents (Al-Shawi et al., 2008) and an increase in 
proNGF levels in the projection areas of some of these populations (Bierl and Isaacson 
2007; Al-Shawi et al., 2008).  These findings, together, confirmed that proNGF and 
sortilin play a key role in mediating neurotoxic effects in neurotrophin-responsive 
neurons in ageing.  Further evidence has also demonstrated the neurotoxicity of 
proNGF in response to injury in adult mice (Harrington et al., 2004) and during AD in 
human cortical neurons (Peng et al., 2004; Pedraza et al., 2005).  
Neurotrophic activities of proNGF have also been observed in adult neurons (Al-
Shawi et al., 2008).  Although the conditions which determine the ultimate outcome of 
cell activities through proNGF are still unknown (Ibanez 2002), it is likely that the 
ratio of TrkA to p75NTR/sortilin expressed at the cell surface is a contributing factor 
(Fahnestock et al., 2004; Al-Shawi et al., 2008; Clewes et al., 2008; Masoudi et al., 2009).  
Reverse transcription polymerase chain reaction (RT-PCR) on SCG neurons by Cowen 
et al., (2003) found that TrkA expression remained stable during mature adulthood 
and old age, while p75NTR expression is largely reduced.  However, dynamic 
regulation of the latter occurs after insult or injury in the brain (Kokaia et al., 1998; 
Roux et al., 1999; Ramos et al., 2007) and spinal cord injury models (Ernfors et al., 
1989; Koliatsos et al., 1991; Hayes et al., 1992).  Further studies indicate that this is 
variable and may depend on the cell type; p75NTR down-regulation in sensory neurons 
but up-regulation in local glial cells has been observed, post injury (Li et al., 2008). 
Altogether, a local up-regulation of p75NTR, combined with higher levels of proNGF, 
released after injury (Beattie et al., 2002; Volosin et al., 2008), supplemented by the 
presence of sortilin may shift the balance of neuronal fate towards cell-death and may 
constitute a mechanism to eliminate damaged cells.  Jansen et al., (2007) adds that, in 
SCGs, this is coupled by a reduction of target-derived mature neurotrophins during 
age-dependent axonal dystrophy. 
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1.3.2 Neurotrophic signalling - Downstream 
 
NGF engagement of Trk receptors initiates survival-promoting signal transduction in 
developing sympathetic neurons through activation of GTP binding protein Ras, 
which mediates two intracellular pathways: Mitogen-activated protein kinase 
(MAPK)/extracellular signal-related kinases (ERK) (Xia et al., 1995; Nobes et al., 1996; 
Grewal et al., 1999; Mazzoni et al., 1999; Kaplan and Miller 2000) and 
phosphatidylinositol 3-kinase (P13K)/AKT (Holgado-Madruga et al., 1997; Philpott et 
al., 1997; Crowder and Freeman 1998; Vaillant et al., 1999).  Both pathways also have a 
role to play in axon and neurite outgrowth (Markus et al., 2002; Song and Yoo 2011) 
by maintaining and steering growth cone structure (Song et al., 1997; Ming et al., 2002; 
Atwal et al., 2003).  P13K can also be activated independently of Ras (Datta et al., 
1999; Yuan and Yankner 2000) and signals other downstream effectors, which 
influence survival e.g. inhibitor of apoptosis (IAP) family of caspase inhibitors (Wiese 
et al., 1999).   
 
The P13K/Akt pathway promotes survival by directly inhibiting the activity of 
apoptotic proteins, e.g. Bad and Forkhead, or through blocking c-Jun terminal kinase 
(JNK), members of the MAPK family, and subsequent p53-Bax-dependent apoptosis.  
It also works by indirectly increasing anti-apoptotic proteins, e.g. IAP and Bcl-2 (Datta 
et al., 1997; Kaplan and Miller 2000).   In contrast, MEK/MAPK promotes NGF-
dependent survival by directly stimulating the activity or expression of anti-apoptotic 
proteins, including Bcl-2 (Aloyz et al., 1998) and the transcription factor CREB (cAMP 
response element binding protein) (Riccio et al., 1999).  NGF was found to 
significantly increase Bcl-2 levels in sympathetic neurons (Aloyz et al., 1998), which 
subsequently protected these and other neurons from apoptotic cell death 
(Michaelidis et al., 1996).  Further detail into the pathways controlled through these 
proteins has been reviewed (Kaplan and Miller 2000; Huang and Reichardt 2003). 
  
Rac1 and Cdc42, members of the Rho GTPase family, are also implicated in NGF-
dependent signalling and have been shown to positively regulate neurite extension 
through re-organisation of the actin cytoskeleton, via a p75NTR-dependent pathway 
(Yamashita et al., 1999; Harrington et al., 2002).  Both Rac1 and Cdc42 are activated 
very early in response to NGF in PC12 cells (Aoki et al., 2004).  Immediately after 
NGF addition, Rac1 and Cdc42 are transiently activated in the periphery and 
recurrent activation is also observed in the tips of the protrusions.  
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Following p75NTR activation, the recruitment of adaptor protein complexes is 
necessary to promote further signalling due to a lack of intrinsic catalytic activity 
(Hempstead 2002; Bandtlow and Dechant 2004; Gentry et al., 2004; Hasegawa et al., 
2004).  Several of these have been associated with trophic deprivation-dependent 
apoptosis in developing sympathetic neurons.  These include NRIF (Casademunt et 
al., 1999; Linggi et al., 2005), TRAF6 (Yeiser et al., 2004), and the MAGE family 
members: NRAGE (neurotrophin receptor–interacting MAGE homologue) (Salehi et 
al., 2000; Kendall et al., 2002; Ceni et al., 2010) and Necdin (Tcherpakov et al., 2002; 
Kuwako et al., 2004).  
The p75NTR adaptor protein, NRAGE was implicated in p75NTR-dependent cell death of 
NGF-dependent sympathetic neurons during development, through activation of 
JNK (Salehi et al., 2000; Kendall et al., 2002).  Not solely associated with NGF 
signalling, sympathetic neurons derived from a neonatal NRAGE knockout mouse 
model were also found to be resistant to BDNF/p75NTR/JNK-mediated cell death 
(Bertrand et al., 2008).  However, less is known about the impact of NRAGE and other 
adaptor proteins in NGF-responsive neurons during ageing. 
 
Rac1 and Cdc42, MAPK activators, are also involved in JNK-dependent apoptosis, 
following NGF withdrawal, in developing sympathetic neurons.  Over-expression of 
constitutively active forms of Rac1 and Cdc42 leads to JNK activation, and results in 
the subsequent death of sympathetic neurons.  Conversely, overexpression of 
dominant-negative mutants of Cdc42 and Rac1 in sympathetic neurons prevents 
elevation of JNK, c-Jun transcription factor, and cell death (Bazenet et al., 1998).   
 
1.3.3 JNK responses  
 
JNKs have received considerable attention since their initial discovery 20 years ago 
(Kyriakis and Avruch 2001).  Essential for the regulation of growth and survival 
signalling, they play an important role in the formation of the developing nervous 
system, but also in response to injury or insult of the adult nervous system (Yamasaki 
et al., 2012) and age-related diseases (Brecht et al., 2005). 
The significance of JNK signalling in p75NTR-mediated apoptosis, following trophic 
withdrawal in early development, has already been established in sympathetic 
neurons (Eilers et al., 1998; Eilers et al., 2001), central neurons (Friedman 2000; Troy et 
 
 
Introduction 
 
  	
 27 
al., 2002; Bhakar et al., 2003; Becker et al., 2004) and non-neuronal cells (Casaccia-
Bonnefil et al., 1996; Beattie et al., 2002).  
 
In ageing, the focal point of JNK research has remained with neurodegenerative 
diseases; in the CNS, e.g. Parkinson’s disease (PD) (Brecht et al., 2005), Alzheimer’s 
disease (AD) (Morishima et al., 2001; Zhu et al., 2001; Savage et al., 2002; Vogel et al., 
2009; Killick et al., 2014), and in the PNS, e.g. myelin breakdown (Gomez-Sanchez et 
al., 2015).  These associations have led to the investigation of JNKs as potential 
therapeutic targets for neuroprotection (Manning and Davis 2003; Bogoyevitch et al., 
2010; Antoniou et al., 2011).  In vivo studies on adult sensory neurons have also 
reported JNK involvement in the process of regeneration (Kenney and Kocsis 1998; 
Barnat et al., 2010; Ruff et al., 2012), which is discussed later (Results 3.1.1.4).   
 
It is believed that the multi-faceted nature of JNK regulation in the nervous system 
leads to an integrated and input-balanced signalling outcome (Morrison and Davis 
2003) whereby differential regulation can be determined by the age of the neuron or 
the state of the environment.  Different cell types have varying outcomes as well e.g. 
while survival of neonatal sensory neurons is reduced by JNK inhibition in the 
presence of NGF, there is no effect on the survival of cultured sympathetic neurons 
from the same developmental stage (Lindwall and Kanje 2005).  Similarly, neurite 
outgrowth is JNK-dependent for early postnatal hippocampal but not for cortical 
neurons (Eminel et al., 2008).  
 
JNK signal variation can be applied through different isoforms.  The JNK family 
consists of three related genes: JNK1 and JNK2, which are present in most tissues, and 
JNK3, which is predominantly found in the brain and testes.  Diversity is 
accomplished by splicing each gene to create ten JNK isoforms, all of which share an 
epitope that requires dual phosphorylation for JNK activation.  Located downstream 
of various signalling pathways, activated phospho-JNKs subsequently phosphorylate 
several protein substrates (~50 have been discovered).  JNK substrates are localised 
throughout the cell including dendrites, axons and presynaptic endings (Coffey et al., 
2000; Chang et al., 2003; Bjorkblom et al., 2005; Tararuk et al., 2006).  Proteins residing 
in the nucleus that are phosphorylated by JNK include transcription factors (AP-1, c-
Jun, ATF2 and p53) and hormone receptors, while non-nuclear substrates include 
those involved in protein degradation (the E3 ligase Itch), signal transduction 
(adaptor and scaffold proteins, and other kinases), apoptotic cell death (mitochondrial 
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Bcl-2 family members), and cell movement (paxillin, doublecortin (DCX), microtubule 
associated proteins (MAPs), and stathmin (SCG10) (Hibi et al., 1993; Kawauchi et al., 
2003; Gdalyahu et al., 2004; Bogoyevitch and Kobe 2006; Tararuk et al., 2006).  
 
Stress-induced or physiological responses facilitate MKK4 and MKK7 
phosphorylation and activation of JNK via a sequential MAPK cascade (Fig 1.2) 
(Wang et al., 2007; Asaoka and Nishina 2010; Haeusgen et al., 2011).  Binding of 
MKK4 and MKK7 to D domains in the N-terminal region of JNKs is very specific e.g. 
JNK1 and JNK2 do not interact with the same domains of other MKKs (Bardwell et 
al., 2009).  Whilst MKK7 has single specificity for JNKs, MKK4 can also phosphorylate 
p38 MAPKs (Davis 2000), which must be taken into account when targeting MKK4.  
The binding affinity of each isoform to MKK is also different, and can influence signal 
diversity i.e. MKK4 has a higher binding affinity to JNK1 and JNK3 than JNK2 (Ho et 
al., 2003). 
 
Signal differentiation may also be achieved by intracellular concentrations of binding 
partners, which can determine the resulting inhibitory or activating effect of MKKs on 
JNKs (Kieran et al., 1999).  Following JNK activation, the formation of multi-enzyme 
complexes, which include the scaffold JNK-interacting proteins JIP1 to JIP4 (Dickens 
et al., 1997; Whitmarsh et al., 1998; Ito et al., 1999; Yasuda et al., 1999; Kelkar et al., 
2000), and other proteins, drives regulation and contributes to signal specificity by 
binding and sequestering selective MAPK components to a restricted region of the 
cell, depending on the type of stimulus. 
 
Therefore, localisation of JNK can also be a defining factor; nuclear JNK influences 
JNK-mediated cell death after the withdrawal of neurotrophic support in neonatal 
CNS neurons (Bjorkblom et al., 2008), while effects on neurite outgrowth can be 
mediated by JNK phosphorylation of cytoplasmic targets, as displayed in the 
developing cerebellum (Bjorkblom et al., 2005), cortex (Westerlund et al., 2011) and 
also during axonal regeneration in adult DRG (Barnat et al., 2010).  It is important to 
note that when observing subcellular compartmentalisation, JNKs are not always 
static e.g. JNK3 translocates from the cytoplasm to the nucleus in pyramidal neurons 
of the hippocampus, in response to stress induced by hypoxia (Zhang et al., 1998).   
 
The outcome of JNK signalling can also be influenced by the time course of activation.  
Sustained JNK activation produces an apoptotic response in cerebellar granule 
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neurons (CGN) (Chen and Tan 2000) whereas, in human breast carcinoma cells, many 
cytokines cause only transient JNK activation, making apoptosis less likely (Liu et al., 
1996).  Cells may also interpret transient JNK activation as a survival signal because of 
the activation state of other signalling pathways within the cell.  It has been 
previously described that during most forms of environmental stress, apoptosis is 
inactive because the JNK-dependent apoptotic signalling pathway is blocked by 
activation of survival signalling pathways (Xia et al., 1995) such as Akt/P13K, and 
ERK.    
 
 
 
 
Figure 1.2: JNK cascade model in neuronal growth and stress signalling	
 
The three-tiered core signalling module of MAPK, MAPKK and MAPKKK (signalosome) is 
composed by scaffold proteins in a situation- and cell type-specific manner (Waetzig et al., 
2006).  
 
The manner by which JNK isoforms operate can facilitate different outcomes as well.  
In a kainic-acid induced injury (excitotoxicity) model in mouse hippocampal neurons, 
JNK1 knockouts increased site-specific neurodegeneration, while seizures were 
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prevented in JNK3 KOs (Brecht et al., 2005).  This is supported by post-injury 
ischemic (transient middle cerebral artery occlusion) in vivo studies (stroke model), in 
rat brain mitochondra, where the number of MKK4:JNK3 complexes rises but the 
concentration of MKK4:JNK1 decreases (Zhao and Herdegen 2009).  
 
Although JNKs are mainly known for their function in pro-apoptotic signalling, their 
influence on neurite outgrowth in development (Coffey et al., 2000; Oliva et al., 2006; 
Tararuk et al., 2006; Qu et al., 2013) and in the regeneration of the damaged adult 
peripheral nervous system (Kenney and Kocsis 1998; Lindwall et al., 2004; Barnat et 
al., 2010; Ruff et al., 2012) has also been documented.  Isoform-specific activation has 
also been observed here; in the PNS, neuritogenesis is delayed by lack of JNK2 and 
JNK3, but not JNK1 during the axonal regeneration of adult mouse DRG.  However, 
sustained neurite elongation relies on JNK1 and JNK2 (Barnat et al., 2010).   
As mentioned, age is also a defining factor in the influence of different isoforms e.g. 
JNK1 and JNK2 are important for regulating apoptosis in the developing nervous 
system (Kuan et al., 1999), while JNK3 is a key mediator in p75NTR-dependent 
apoptosis of neonatal neurons following trophic deprivation (Bruckner et al., 2001; 
Pirianov et al., 2007; Kenchappa et al., 2010) but also during the neurotoxicity 
associated with ageing and disease (Brecht et al., 2005).  Further JNK knockout 
phenotypes have been reviewed (Bogoyevitch and Kobe 2006; Coffey 2014). 
While research has centred around isoform-specific JNK inhibition as a way to confer 
neuroprotection and advance our understanding of signalling mechanisms associated 
with neurodegenerative diseases in the brain, there have been fewer studies on the 
effects of JNK inhibition in the ageing PNS. 
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1.4 Peripheral Nerve Injury 
 
Peripheral nerves are less protected than the CNS, which utilises the blood–brain 
barrier (BBB) to defend against penetration of proteins and other molecules from the 
circulating blood.  This leaves the PNS neurons exposed to toxins and mechanical 
injuries and is perhaps why peripheral networks have evolved the ability to 
regenerate. 
Axon injury can be caused by trauma, toxic insults, and neurodegenerative and 
genetic disorders (Coleman 2005; Wang et al., 2012), resulting in a loss of motor, 
sensory or autonomic control of target organs.  Enforced changes can be observed 
within the external cell environment, including nutrients, growth factors, cytokines 
and cell matrix adhesion factors (Ide 1996).  In the CNS, injured axons struggle to 
regenerate due to a combination of low intrinsic growth potential and environmental 
factors (Bradke et al., 2012), while injured neurons in the PNS can show robust 
regeneration.  In many cases, this renewal is slow and the target cell degenerates or 
becomes non-functional before re-innervation eventually occurs (Bradke et al., 2012). 
This can be hindered even more in ageing (Tanaka and Webster 1991; Verdu et al., 
2000; Pan et al., 2003; Kennedy and Zochodne 2005), primarily due to decreased 
macrophage recruitment and Schwann cell (non-neuronal) reactivity (Komiyama and 
Suzuki 1992).    
The process of regeneration is triggered, following injury, when local responses 
promote resealing of the injured axon and re-organisation of the cytoskeleton to make 
way for growth cone formation (Bradke et al., 2012).  Concurrently, local signalling 
pathways activate and promote retrograde transport of injury signals to the nucleus, 
which subsequently initiates a pro-regenerative transcriptional program (Tedeschi 
2011) and shifts neurons into a regenerative state.  Efficient axon regeneration is 
delayed until this state has been induced (Smith and Skene 1997).  
More specifically, the affected area undergoes a four-step regeneration process, which 
includes Wallerian degeneration (breakdown of the separated axon) and 
chromatolysis (dissolution of Nissl bodies within neurons), axonal regeneration, 
target innervation and axonal maturation (Verdu 1998).  At 2-3 days after injury, in 
order to remove any unwanted debris, there is an influx of macrophages within the 
degenerating nerve.  To assist with this process, macrophages secrete cytokines to 
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promote the mitosis of reactive denervated non-neuronal Schwann cells, which 
become phagocytic.  Schwann cells help with the degradation of myelin debris, but 
also secrete neurotrophic factors to promote axon elongation.  
In adult and aged sympathetic networks, a number of studies have demonstrated that 
NGF can promote regeneration and increase the sympathetic innervation of 
peripheral targets in injured (Bjerre et al., 1975; Saffran et al., 1989) and uninjured 
axons (Isaacson et al., 1990; Saffran and Crutcher 1990; Isaacson and Crutcher 1998).  
The latter studies, performed in vivo, reported that intra-cerebral NGF administration 
induces sympathetic hyper-innervation of target CV vessels in aged rat.  
Administration using miniosmotic pumps (Andrews and Cowen 1994a) also 
demonstrated that exogenous NGF could induce organotypic neurite outgrowth from 
aged neurons undergoing nerve fibre atrophy.  Here, dendritic arborisation (dendritic 
and cell body growth) was observed in response to NGF but primary dendrites and 
branch points were not affected.  While they are still NGF-responsive, aged SCG 
neurons exhibit a decreased ability to mediate collateral sprouting in response to a 
partial denervation of a target (Kuchel and Zigmond 1991; Kuchel 1993) or following 
the exogenous administration of physiological levels of NGF (Gavazzi 1995).  
Interestingly, Andrews and Cowen (1994a) revealed that administration of NGF into 
the middle cerebral artery of aged rats, induced greater nerve growth in aged 
compared to young nerves, suggesting differential and developmental regulation.   
A commonly used method for studying the effects of injury on the nervous system is 
the sectioning of nerves (axotomy), usually postganglionic, which causes a variety of 
pathological changes in the neuronal somata (Taxi and Eugene 1995).  Not long after 
axotomy, thin axonal sprouts or growth cones develop from the proximal nerve 
segment, which create amoeboid-like extensions to allow elongation of nerves.  
Growth is the result of increased synthesis in the neuronal body of proteins and other 
materials that pass distally to the axon tip through axonal transport.  The direction of 
the advancing tip changes depending on the physical and chemical properties of the 
adjacent distal environment and the neurotrophic factors produced by non-neuronal 
cells (Fawcett and Keynes 1990).  
After sprouting has been initiated, Schwann cells secrete components of basal lamina 
to stimulate and guide regeneration.  The relevant molecules include laminin, 
fibronectin and several others embedded within the extracellular matrix (ECM), the 
environment that provides structural and biochemical support to the surrounding 
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cells.  The regenerating axons express integrins to mediate recognition of the ECM 
and the subsequent intracellular signalling that facilitates neuronal growth.  Del 
Signore et al., (2006) identified changes in the expression of a number of molecules in 
the rat SCG after postganglionic axotomy including collagen α1 type I and III, 
intermediate filament proteins, and modulators for neurite outgrowth such as 
thrombin receptor and BMP-4.  Once muscles are re-innervated, maturation 
completes the process and restores nerve conduction through myelination, although 
this is delayed in ageing.  Over 200 genes in adult rat SCG were found to have 
alterations after axotomy (Boeshore et al., 2004), making it an exceedingly complex 
topic.  As discussed before, p75NTR up-regulation is also observed in Schwann cells 
(Lemke and Chao 1988; Taniuchi et al., 1988) and oligodendrocytes (Beattie et al., 
2002) following peripheral damage and has been shown to be important for Schwann 
cell myelination and re-myelination during regeneration (Cosgaya et al., 2002).   
Post-injury repair in the periphery has traditionally been researched in vivo, either by 
transplantation studies (Gavazzi et al., 1992; Gavazzi and Cowen 1993a; Gavazzi and 
Cowen 1993b), conditioning lesion or drug application into the DRG, or sciatic nerve, 
followed by an axonal growth assay, either in vivo or in culture (McQuarrie and 
Grafstein 1973; Kilmer and Carlsen 1984; Smith and Skene 1997; Neumann et al., 2002; 
Qiu et al., 2002).  At the time of this study, it was recognised that axotomy of 
peripheral neurons (DRG) by dissociating and then culturing them also initiates the 
activation of injury-activated transcription factors and up-regulation of regeneration-
associated genes (Zou et al., 2009; Saijilafu et al., 2013).  Furthermore, this injury 
activates neurite outgrowth in a manner similar to in vivo conditioning lesions.  
Although this has been observed in sensory neurons, the same may also be true for 
sympathetic motor neurons, and culturing these neurons could provide an insight 
into the processes that are associated with injury in vivo.  
 
 
1.5 Glia 
 
Historically, glial cells have been treated as passive non-excitable elements of the 
nervous system, mainly providing neuronal support.  Pre-assigned roles include 
maintaining a functional synaptic environment to guiding developing axons, forming 
the blood-brain barrier, nourishing neurons, and myelinating axons.  However, over 
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the last two decades, evidence has gathered to challenge this traditional view.  The 
use of animal models has shown that actually there is not a single function in the 
nervous system that occurs without the contribution of glial cells.  Therefore, for 
neuroscientific progression, further understanding of the interaction between neurons 
and glia is absolutely vital. 
 
The majority of neuronal synapses are enveloped by, or in contact with glial cell 
processes (Auld and Robitaille 2003; Hanani 2010).  In the CNS, there are three types 
of glial cell: astrocytes, oligodendrocytes and microglia, while satellite glial cells and 
Schwann cells reside in the PNS.  As discussed before (1.4), Schwann cells have an 
important role during peripheral nerve regeneration, however, another role for these 
cells is to confer neuroprotection and axon protection, a property shared by astrocytes 
in the brain.  Similarly, there is evidence to indicate that satellite glial cells have a 
significant role in the response to nerve damage (Hanani 2010). 
 
Glial cells also release trophic factors, neuroprotective molecules, and 
neurotransmitters essential for neuronal survival and function (Toku et al., 1998; 
Tanaka et al., 1999; Hansson and Ronnback 2003; Montana et al., 2006).  Equally, all 
glia present a variety of receptors for neurotransmitters, hormones and other 
bioactive molecules (Jabs et al., 2005) thus providing a way for glia and neurons to 
communicate.  Not only do neurotrophins support neurons but they also contribute 
to glial cell development and survival (Althaus and Richter-Landsberg 2000; Syroid et 
al., 2000; Chan et al., 2004; Husson et al., 2005; Yamauchi et al., 2005).  Like glia in the 
brain, Schwann cells express receptors for neurotrophins and respond to 
concentration changes of neurotrophins within the extracellular space.  This has been 
reviewed (Elkabes et al., 1996; Althaus and Richter-Landsberg 2000; Hempstead and 
Salzer 2002; Chan et al., 2004).  In fact, in transected nerves, Schwann cells can survive 
even in the absence of axons, by establishing an autocrine circuit of trophic factor 
production (Meier et al., 1999).  In degenerative conditions, this endurance of 
Schwann cells allows them to regulate the survival and differentiation of neurons.  
Further downstream, another property that glial cells share with neurons is the 
regulation of survival and differentiation by JNKs, both in the CNS (Casaccia-Bonnefil 
et al., 1996; Ladiwala et al., 1998; Yoon et al., 1998; Jurewicz et al., 2003; Pirianov et al., 
2006) and the PNS (Parkinson et al., 2004).  This is discussed further (Results 3.2.1). 
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1.6 Experimental models in ageing 
 
Research into the process of ageing carries unique challenges and to avoid using 
invasive methods to study the pathophysiology of neurodegenerative diseases in 
humans, a variety of animal models have been developed.   
 
Non-surgical models aim to replicate disease conditions that are associated with 
ageing, and the use of laboratory animals (mainly rodents) offers a way to carefully 
characterise anatomical, physiological and behavioural aspects aligned with these 
conditions.  Recent work in genetics and in comparative biology confirms that ageing 
exhibits common characteristics across species.  It is now apparent that some of the 
hormones and cellular pathways that influence the rate of ageing in lower organisms 
also contribute to many of the manifestations of ageing that we see in humans 
(Sinclair and Guarente 2006). 
 
Although ageing models are expensive and translation to the clinic is not always 
straightforward, these models have enhanced our understanding of the cellular and 
molecular mechanisms involved in later life, as well as identifying candidate 
compounds for use in clinical trials.  
 
Where possible it is important to complement non-surgical studies with in vitro 
studies of wild-type aged models to further define molecular pathways.  In particular, 
genetic manipulations and the use of targeted inhibitory compounds on cultured cells 
have helped with the molecular dissection of important biological pathways in 
normal and diseased states. 
 
In the past, the difficulty of maintaining cells derived from adults steered 
experimental work towards the use of embryonic or postnatal cells, until the first 
studies in ageing sympathetic neurons began with Uchida and Tomonaga (1985).  
Dissociated sympathetic neurons from young and aged mice were cultured on 
different substrata, using either collagen or polyornithine-binding components of 
heart-cell-conditioned medium (HCM).  They found that the ability of sympathetic 
neurons to respond to HCM is affected in old age, and changes depending on the 
substratum but also on the parameter measured.   
 
 
 
Introduction 
 
  	
 36 
Soon after, different components of the extracellular matrix (ECM) were found to 
provide spatial cues to growing neurons in development and regeneration in vivo 
(Sanes 1989; Reichardt and Tomaselli 1991; Letourneau et al., 1994).  Many 
experimental studies then recognised the importance of protein constituents in the 
(ECM) in influencing some aspects of neural differentiation.  For example, Cowen et 
al., (1997)  discovered a positive growth response of aged neurons in the presence of 
basement membrane glycoprotein, laminin, and NGF.  Explant cultures of 
sympathetic neurons from mature and aged rat SCG were grown on substrata 
containing different doses of laminin.  Only when exogenous NGF was added, was 
there a powerful effect on nerve growth (Cowen et al., 1997).  Collagen type I and 
collagen type IV were also shown to promote process outgrowth in neurons and non-
neuronal cell types (Reichardt and Tomaselli 1991; Letourneau et al., 1994; Cowen et 
al., 1997) in the presence of NGF (see Materials & Methods 2.2).  
After the initial work by Uchida and Tomonaga (1985), further studies failed to 
pinpoint the possible contributions of serum and non-neuronal cells to the survival 
and growth of neurons in culture.  So, Orike et al., (2001a) established a technique for 
the dissociation, purification and culture of sympathetic neurons from adult and aged 
rat SCG under serum free conditions, and in defined media.  Crucially, this method 
produced a high yield of viable growing neurons, meaning that subpopulations of 
neurons could be sampled, and gave a better indication into the influence of 
surrounding factors. 
(Orike et al., 2001a) describes the viability of neurons in culture as being underpinned 
by two vital steps: 
(i) enzyme digestion, which is adjusted depending on the age of the donor 
animal. Extended incubation times with collagenase are important for the 
successful dissociation of adult and aged neurons. 
(ii) sequential trituration, with a fire-polished pipette, the tip diameter of which 
is close to the size of the segments of ganglion being dissociated. The process 
of trituration (see Materials & Methods 2.2) generates approximately 10% of 
the total number of neurons from aged ganglia, 30% from neonatal ganglia 
and an intermediate value for young adult ganglia. 
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The use of small-interfering RNAs (siRNAs) in animal cultures has provided another 
useful way to study protein function in neurons using a highly efficient and non-toxic 
method.  First discovered by Fire et al., (1998), RNA interference is a process by which 
double stranded RNAs (siRNAs), once delivered inside a cell, are processed into short 
RNA duplexes, which have the ability to promote mRNA degradation and the 
silencing of specific genes (Felekkis and Deltas 2006).  Synthetic siRNAs linked to cell-
penetrating peptide Penetratin-1 has allowed for quick and effective uptake of siRNA 
in whole populations of primary SCG neurons (Davidson et al., 2004).   
 
1.7 Treatment of ageing 
 
Despite being a complex area of research, a growing body of evidence has alerted 
researchers to the possibility of scientific intervention methods to slow ageing and 
significantly reduce the risk of age-related disease.  Several studies on animal models 
have demonstrated that ageing rates and life expectancy can be modified, through 
altering reproduction, reducing caloric intake, or changing the signalling pathways of 
specific physiological mechanisms (Yu et al., 1985; Brown-Borg et al., 1996; 
Weindruch and Sohal 1997; Flurkey et al., 2001; Tatar et al., 2003).  In fact, drugs to 
slow the ageing process already exist.  Everolimus, a cancer drug, and Metformin, 
used in Type II diabetes patients, are just two examples of compounds already in 
circulation that combat specific diseases but possess the ability to slow ageing as well 
(Anisimov et al., 2008; Harrison et al., 2009; Spong and Bartke 2012; Anisimov 2013b; 
Anisimov 2013a; Blagosklonny 2013). 
 
However, the administration of a therapy involving proteins in the brain has inherent 
problems.  Because of the blood–brain barrier, the protein must be infused directly, 
produced by viral constructs, secreted from implanted protein-secreting cells or 
actively transported across the brain.  An alternative to this is to use small molecule 
agonists, modulators or enhancers to target the receptors or intracellular signalling 
molecules associated with a specific pathway.   
 
The use of JNK inhibitors (Scapin et al., 2003) has intensified as a neuroprotective 
strategy (Borsello et al., 2003; Hunot et al., 2004), but also to help deduce the 
physiological and pathological functions of JNKs, their isoforms, and the molecular 
pathways that control this.  This is discussed in more detail later (3.1.1.6). 
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1.8 Aims of the project 
 
There are marked differences in the survival characteristics between neurons in 
development compared to those in aged adult animals.  While neonatal sympathetic 
neurons are extremely dependent on NGF for survival, this dependency is largely 
reduced in ageing (Orike et al., 2001b; Al-Shawi et al., 2008).  Despite this, aged 
neurons are still NGF-responsive and NGF-dependent neurite outgrowth is still 
viable.  The NGF precursor, proNGF, can also promote neuritogenesis of young adult 
and aged neurons, but has additionally been found to mediate neurotoxicity in a sub-
population of NGF-responsive neurons of the aged PNS and CNS.   
 
Differential and developmental regulation of neurotrophic signalling mechanisms can 
be determined by a number of factors from receptor (p75NTR, TrkA, sortilin) 
expression to the availability of ligands and regulatory proteins within the cell.  A 
large body of work has revealed much about receptors and upstream effectors in 
ageing but a closer look into downstream effectors is necessary.   
 
The hypothesis in this study is that JNK signalling is important for the regulation of 
NGF-promoting growth and proNGF-mediated signalling in NGF-responsive young 
adult and aged peripheral neurons.  It is also proposed that NRAGE is involved in 
this process.   
 
JNK inhibitor studies and siRNA knockdown of NRAGE within a modified cell 
culture method for adult and aged SCG neurons, which monitors the growth and 
survival, will seek to determine the impact of JNK and NRAGE on NGF and proNGF 
signalling.  Isoform–specific interactions will also be taken into account and further 
inhibitor studies will look to verify the importance of different JNK isoforms in 
neurotrophic signalling within adult and aged sympathetic neurons. 
 
While neurons have been thoroughly studied, glia are also essential to the outcome of 
various signalling pathways.  So, it will also be important to visualise the effects of 
various inhibitors on SCG glia in culture.  
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2.1 Animals 
 
Healthy, C57BL/6J x CBA/Ca young adult (3-6 months) and old (24-36 months) male 
mice were used in all culture experiments from colonies maintained at University 
College London.  Mice were fed RM1 special diet services (SDS) ad libitum (AL).  
RM1 is composed of 14.4% crude protein, 2.7% oil, 4.6% fibre and 90% dry matter, 
with a caloric content of 14.7 MJ ⁄ kg.  
 
All animal studies were ethically reviewed and approved by the UCL Royal Free 
Campus Ethics and Welfare Committee and the UK Home Office, and were carried 
out in accordance with European Directive 86/609/EEC.  Mice were killed using 
carbon dioxide (CO2) inhalation. 
 
2.2 Young Adult and Aged SCG neuron Cell culture 
 
Dissociated primary adult SCG neuron cultures were prepared as previously 
described (Gavazzi et al., 1999; Orike et al., 2001b; Al-Shawi et al., 2008).  Briefly, 3-4 
SCGs were aseptically excised and desheathed in Hanks medium containing Hepes 
buffer (0.01M) and Penicillin/Streptomycin (0.05mg/ml), then placed on ice.  
Exposed SCGs were cut into 4-5 pieces then digested with 2ml Hanks containing 
collagenase type XI (1mg/ml) (Sigma, UK) and bovine serum albumin (BSA) 
(6mg/ml) (Sigma, UK) for approximately 30 mins to 1 hour, at 37°C and 5% CO2, in a 
humidified incubator.  SCGs were then washed in Hanks solution twice before the 
addition of 2ml Hanks containing Trypsin (1mg/ml) (Sigma) and BSA (6mg/ml), for 
ten minutes at 37°C and 5% CO2, in a humidified incubator.  Ganglia were washed 
twice in Hanks medium and pelleted by centrifugation (1min x 42gmax) in between.  
Ganglia were mechanically dissociated in 500#l of Neurobasal-A medium (NBM) 
supplemented with B27 (Gibco, UK), L-Glutamine 2mM and Penicillin/Streptomycin 
(0.05mg/ml) and 3#M cytosine arabinofuranoside (AraC; Sigma, UK) for 24 hours, 
unless otherwise indicated.  For proNGF cultures (Results 3.3), some experiments 
were carried out with B27 supplement in the absence of insulin (Gibco, UK).  
Trituration was performed using sterilised, siliconised, fire-polished glass pipettes 
firstly with a pore size of 0.30-0.40mm and then subsequently with a pore size of 0.15-
0.20mm.  A maximum of 4 triturations were carried out before supernatant medium 
was decanted into another Falcon tube.  Fresh medium (approx 300-500#L) was 
added to the original Falcon tube and a further 4 triturations were performed before 
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the supernatant was decanted again.  This process was repeated until no cell clusters 
could be seen and the majority of neurons were removed.  Neurons were plated on 
glass coverslips (VWR International) at a density of 300/well unless otherwise stated.  
Pre-sterilised* coverslips were pre-coated by sequential incubation with human 
collagen IV (Sigma) for 5 hours at 37°C and 5% CO2, then at 4oC until use.  Once 
plated, and after the inclusion of various factors, cultures were allowed to settle for 20 
minutes before incubation at 37°C in a humidified 5% CO2 chamber.  
 
Neuronal survival and neurite outgrowth was followed for 24 hours of culture, unless 
otherwise stated.  When obtaining data for 72 hours, similar survival and growth 
rates relative to controls were acquired for consecutive days.  
 
*Coverslips were placed in a glass petri dish containing acetone for 40 minutes then 
absolute ethanol for 20 minutes at room temperature.  Ethanol was decanted followed 
by the addition of 0.1M Hydrogen Chloride in the fume cupboard.  Coverslips were 
rinsed 3 times in 18.2 M$·cm sterile H2O followed by 8 washes x 3 minutes.  3 more 
rinses were performed before placing in the drying cabinet.  The petri dish was 
mounted on a shaker during washes to allow complete coating of the coverslips.   
 
Table 2.1: Growth Factors 
 
Factor Source 
NGF (murine 2.5S) Promega, UK 
Furin cleavage-resistant  
proNGF  (mutated-
mouse) N-255 
Alomone labs 
Human recombinant 
proNGF Scil Proteins Axxora 
 
Robust growth of rat SCG neurons was observed previously in adult neurons cultures 
when NGF (Promega mNGF 26kDa) and proNGF were used at 0.4nM (Orike et al., 
2001a; Al-Shawi et al., 2008), similar to the physiological concentrations measured in 
adult rat SCG and iris (Cowen et al., 1996).  Therefore the same concentration was 
used in this study unless otherwise stated. 
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2.2.1 JNK inhibitors 
 
Table 2.2: JNK inhibitors 
 
All inhibitors were purchased from Calbiochem, U.K. 
Inhibitor Mode of Action 
 
AEG3482 
 
(6-Phenylimidazo[2,1-b]-1,3,4- 
thiadiazole-2-sulfonamide) 
Binds HSP90 and disrupts the association with heat 
shock protein transcription factor (HSF-1).  Freely 
available HSF-1 subsequently induces the expression of 
HSP70, which blocks JNK activation 
 
JNK Inhibitor II 
 
Also known as SP600125 
SAPK Inhibitor II            
(anthra[1,9-cd]pyrazol-6(2H)-one) 
Cell-permeable peptide and reversible, ATP 
competitive inhibitor.  Exhibits over 300-fold greater 
selectivity for JNK than ERK1 and p38-2 MAP kinases.  
Inhibits phosphorylation of c-Jun. 
IC50: Jnk1/2=40nM  Jnk 3=90nM 
 
JNK Inhibitor III 
 
(Ac- YGRKKRRQRRR-gaba-
ILKQSMTLNLADPVGSLKPHLRAK
N-NH2) 
Cell-permeable peptide.  Specifically disrupts c-
Jun/JNK complex formation and the subsequent 
phosphorylation and activation of c-Jun by JNK both in 
vitro and intact cells.  Can complement JNK signalling 
studies with JNK Inhibitor II, since its mode of 
inhibition is different.  Purity: ≥95% by HPLC. 
 
JNK Inhibitor VIII 
 
(N-(4-Amino-5-cyano-6-
ethoxypyridin-2-yl)-2-(2,5-
dimethoxyphenyl) acetamide 
Cell-permeable pyridinylamide compound.  ATP-
competitive, reversible inhibitor of JNK 1 and 2, and 
JNK 3 at a higher concentration. 
Displays selectivity over 72 other kinases.  Inhibits c-
jun phosphorylation with an EC of 920 nM in HepG2 
cells.  Ki = 2 nM, 4 nM and 52 nM for JNK1, 2 and 3, 
respectively 
JNK Inhibitor IX 
 
N-(3-Cyano-4,5,6,7- tetrahydro-1-
benzothien-2-yl)-1-naphthamide 
 
Potent ATP-binding site target of JNK 2/3.  Under the 
assay conditions. JNK2 and JNK3 (pIC50 = 6.5 and 6.7) 
with selectivity over JNK1, p38α and a panel of > 30 
other kinases   (pIC50 = < 5.0). 
Purity: ≥95% by HPLC. 
 
 
 Materials and Methods 
 
  
 
	
	 43 
Previously published information about JNK inhibitor potency in cell-based assays 
helped to determine the administered concentration in the culture medium of 10#M, 
at the time of plating (Bennett et al., 2001; Holzberg et al., 2003; Salehi et al., 2006; 
Szczepankiewicz et al., 2006; Angell et al., 2007; Vivanco et al., 2007; Gao et al., 2013).  
A higher concentration is necessary with competitive inhibitors (e.g. JNK inhibitors 
II, VIII and IX) due to a high ATP concentration within cells and/or active efflux of 
these compounds in neurons/glia in cell-based experiments, compared with 
biochemical assays on purified proteins. 
 
JNK inhibitor III, a pan-JNK inhibitor that disrupts the JNK-c-Jun interaction (Table 
2.2), was used at a 10-fold lower concentration than previously reported (Holzberg et 
al., 2003) to avoid non-specific effects.   
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2.2.2 Counting 
Survival and growth was monitored using a Nikon microscope to count phase bright 
neurons at 10x magnification.  Neurons were counted by myself and one other person 
(Ivana Slamova), which was consistent across all experiments.   This quickened 
process helped to limit exposure of the cell culture plates to unfamiliar and 
potentially harmful culture conditions.  It also allowed for triplicates of each 
condition per experiment.  Throughout the study, each experiment had plating count 
of (n=300) unless otherwise stated.  Plates were scored at 24 hour intervals.  Due to 
the inherent variability in the survival of untreated control neurons isolated from 
aged mice, results from representative single experiments are shown as these are 
internally consistent. Experiments were repeated in triplicate, and results were only 
deemed to be significant if there was concordance between repeats.  
For analysis of survival, neurons were marked as alive or dead and, for analysis of 
growth, live neurons were classified as growing or non-growing.  Live neurons were 
identified by their large phase-bright, intact cell bodies and neurites (Orike et al., 
2001b), and were clearly distinct from dead neurons, which were dark, possessed 
fragmented soma and neurites, and were often found partly detached from the 
substrate.  Glia were characteristically small and had spindle-shaped phase-grey cell 
bodies.  The following counting criteria were adhered to over the course of the study: 
 
 
Survival was determined by the number of neurons observed as a percentage of the 
total number of neurons in the well at time of plating: Criteria were as follows: 
 
• Phase-bright attached neurons were counted.  Detached floating neurons were 
not counted 
• Phase-bright round neurons without neurites were counted 
• Glia were not counted 
• Neurons attached to glia were not counted (Fig. 2.1; A+B) 
• Neurons with touching cell bodies were not counted  
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Neurite outgrowth was determined by the number of neurons detected as growing as 
a percentage of the total number of living neurons, on that particular day.  Neuronal 
growth was marked if any one of the neurite extensions was longer than the diameter 
of the cell body (Fig. 2.1;  C+D). 
 
 
 
Figure 2.1: Phase contrast images of counting criteria 
 
Scale bar (D) represents 100#m in panels A-E.  Scale bar (F) represents 100#m in that specific 
panel .  (A) and (B) show glia attached to neuronal cell bodies, and would not be counted.  (C)  
a typical growing neuron. (D) a neuron projecting neurites that were not longer than the 
diameter of the cell body and so would be marked for survival, but not growth. (E) a dead 
neuron (F) the same neuron as E at double the magnification. 
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2.2.3 Hoechst Assay 
 
Four day old primary cultures on glass coverslips were fixed for 20 minutes with 4% 
paraformaldehyde (PFA).  Coverslips were removed using forceps and placed in 
coverslip carriers prior to being dipped and washed in PBS three times.  Primary 
antibody was then applied for two hours at room temperature (RT).  Following a 
series of washes in phosphate buffered saline (PBS), the secondary antibody was 
added for 45 minutes (RT).  After the last series of washes, stained cultures were 
mounted on microscope slides with Fluorsave mountant. 
 
The percentage survival of neurons fixed in culture and stained using Hoechst 33342 
(100ng/ml) was similar to counts of live neurons in culture hence the latter method 
was preferred over Live/Dead assay.  It meant the same neurons could be followed 
for a longer period of time especially as some pathways take longer to react. 
 
 
2.2.4 AraC Optimisation 
 
48-72 hours after the plating of dissociated SCG neurons for trial cell cultures, it 
became difficult to count viable growing neurons (Fig 2.3; Panel A+B) due to the 
proliferation and attaching glia. 
 
Over the last decade, researchers have used cytosine arabinoside (-b-D-arabino- 
furanosylcytosine, AraC) as a way of inhibiting glial proliferation and growth in 
neuronal cultures of young mice.  It functions as a DNA-damaging agent that 
interrupts DNA synthesis and kills all proliferating cells.  However, DNA damage can 
also kill post-mitotic cells, such as neurons.  In vitro, AraC is toxic to post-mitotic 
sympathetic neurons (Wallace and Johnson 1989; Martin et al., 1990), through 
activation of two separate cell death pathways (Besirli et al., 2003; Putcha et al., 2003).  
One pathway requires phosphorylation of c-Jun (Besirli et al., 2003; Putcha et al., 
2003) followed by Bcl-2 family member Bax, which mediates mitochondrial 
cytochrome c release and caspase activation (as seen during neurotrophic withdrawal 
in neonatal neurons) (Martin et al., 1990).  The second pathway is Bax-independent 
and is significantly delayed, similar to the delayed death observed in camptothecin-
treated embryonic cortical neurons in the presence of caspase inhibitors or after Bax 
deletion (Stefanis et al., 1999). 
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Importantly, (Besirli and Johnson 2003) discovered that DNA-damage induced c-Jun 
expression and phosphorylation, in P0-P1 rats, was not disturbed during JNK 
inhibition, thus confirming that AraC-induced cell death of neurons is JNK-
independent.  This supported a study indicating that apoptosis in sympathetic 
neurons is induced via a p53-dependent, JNK-independent, mechanism (Anderson 
and Tolkovsky 1999).  However, these experimental culture studies were performed 
on developing neurons so, for the ensuing work, it was important to find the optimal 
concentration for use on ageing neurons without a detrimental effect to the survival 
and growth in culture.   
 
To determine this, AraC was administered at different concentrations to NGF-treated 
cultured aged SCG neurons (Figs 2.2).  In the past, 10#M AraC had been applied to 
younger neuron cultures without noticeable damage to neurons (Orike et al., 2001a), 
so that gave an indication into the concentrations that should be used in this 
experiment.  The growth and survival of aged SCG neurons was monitored for three 
days.  After 48 hours (Fig 2.2), the NGF-mediated neuronal response began to decline 
in the presence of 10#M AraC, although neuronal growth and survival became 
significantly reduced at a concentration of 30#M AraC.  In the presence of 1#M and 
3#M AraC, the survival and neurite outgrowth of aged SCG neurons, compared to 
control, was not significantly different.  
 
The effect of AraC on the morphology of glia in culture was also observed (Fig. 2.3).  
In the absence of AraC, there was extensive glial proliferation and process outgrowth 
(Fig 2.3; A+B).  However, the addition of AraC restricted this physiological response 
to NGF, and the strength of this restriction correlated with an increase in AraC 
concentration, with no glial proliferation and process outgrowth in the presence of 
30#M AraC. 
 
At a concentration of 3#M AraC, glial proliferation and process outgrowth was 
sufficiently restricted and the survival and growth of neurons was maintained.  
Therefore 3#M AraC provided an ideal concentration to limit the proliferation of glia 
without a detrimental effect to aged neurons, and without compromising the 
experiment.  The same results were observed 72 hours after plating and there was no 
visible effect of AraC on glia after 24 hours in culture (results not shown). 
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Figure 2.2: Concentration dependent effect of AraC on growth and survival of 
aged SCG neurons  
 
After 48 hours in culture, the addition of 1#M, 3#M and 10#M AraC did not 
significantly affect the survival and neurite outgrowth of aged SCG, relative to control.  
However, there was a significant effect in the presence of 30#M AraC and growth and 
survival of aged SCG neurons is reduced (p<0.0001).  This was representative of three 
experiments. 
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Figure 2.3: Representative phase contrast images showing the concentration 
dependent effect of AraC on the growth of glia in aged SCG cultures  
 
(A+B) 0#M AraC, (C+D) 1#M AraC, (E + F) 3#M AraC, (G+H) 10#M, (I + J) 30#M.  
After 48 hours in culture, there was clearly strong outgrowth of glial processes in the 
absence of AraC, with many wrapping around neurons (arrow A).  The addition of 
AraC restricts glial process outgrowth and proliferation and this became more 
pronounced with an increase in concentration (C-H).  Complete restriction was 
observed at 30#M (I & J)  (arrow J).  Scale bar=100#m 
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Experimental studies were also conducted to assess whether AraC was having an 
indirect impact on cell survival or growth of aged sympathetic neurons through the 
inhibition of glial proliferation or process outgrowth in culture.  In aged SCG neuron 
cultures containing NGF and JNK inhibitor e.g. JNK inhibitor VIII (Fig 2.4), the 
survival and the proportion of growing neurons did not change significantly, 
following the addition of AraC, compared to control on Day 1.  The equivalent was 
reported on Day 3.  Therefore, AraC was included in all cultures containing JNK 
inhibitors.   
 
 
 
 
Figure 2.4: Effect of AraC on NGF and JNK Inhibitor VIII-treated aged SCG 
neurons 
 
All SCG cultures derived from aged mice contained NGF and JNK inhibitor VIII (10#M) in the 
presence or absence of 3#M AraC.  AraC did not affect the neurite outgrowth or survival of 
NGF and JNK Inhibitor VIII-treated aged SCG neurons on Day 1 or Day 3.  Representative of 
three experiments (n=300). 
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2.3 Neuron and Glia Differentiation 
 
Neurons and glia are clearly distinguishable in culture but for clarity, cell-type 
identity was confirmed by immunohistochemical analysis.  Previously cultured glial 
cells from mouse SCG have been stained with glial fibrillary acidic protein (GFAP) to 
identify glia (de Almeida-Leite and Arantes 2010).  Therefore, the same marker was 
used here, as well as Tuj-1, a neuron specific marker, in dissociated SCG cultures from 
aged mice Fig 2.5.  
 
 
Figure 2.5: Immunohistochemical analysis to confirm neuron and glia 
identification 
 
Dissociated SCG neurons cultured from aged mice stained with GFAP and Tuj-1.  Glia were 
(A) GFAP positive and (B) Tuj-1 negative.  (C) a growing neuron stained with Tuj-1.           
Scale bar = 50#m 
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2.4 Western blot Analysis 
 
SCG tissues were dissected from F1 hybrid mice (n=3) and snap-frozen in liquid 
nitrogen.  Samples were pooled (6 SCG=approx 3mg) then sonicated by six, one 
second bursts at an amplitude of 10 microns, on ice, and lysed in cold homogenisation 
buffer (HB) (200mM Tris pH7.4, 2mM ethylenediaminetetraacetic acid (EDTA) pH7.4, 
2mM ethylene glycol-bis(β-aminoethyl ether)-N,N,N',N'-tetraacetic acid (EGTA) pH 
7.4, 1mM phenylmethylsulfonyl fluoride (PMSF), 0.5% Triton X-100, 1.09g sucrose, 
sodium vanadate), supplemented with protease inhibitor cocktail (1 tablet⁄ 10 mL, 
Roche Molecular Biochemicals, Mannheim, Germany).  For pooled samples 60-70µL 
HB buffer was added.  Brain samples were homogenised in cold HB buffer.  Lysates 
were spun at 14600g at 4°C for 15 minutes.  Western blot analysis was carried out 
using standard procedures, as previously described (Al-Shawi et al., 2008).   
 
Briefly, 25#g of protein extract, in a sample buffer containing a final concentration of 
4% β-mercaptoethanol, was loaded on a 1.5mm x 15 well 4-12% Bis-Tris 
polyacrylamide gel (Invitrogen) and was run using 4-Morpholineethanesulfonic acid		
(MES) SDS buffer (50mM MES, 50mM Tris base, 0.1% SDS, 1mM EDTA pH 7.3) at 95V 
for between 1 hour 45 minutes and 2 hours 20 minutes, on ice.  Proteins were 
transferred to a nitrocellulose membrane (Invitrogen) using an immunoBlot 
(Invitrogen) at 100V for 7 minutes.  Non-specific protein interaction was prevented by 
incubating the membrane with 5% dried skimmed milk powder (Marvel, Sainsbury’s) 
dissolved in Tris-buffered saline (TBS) with 0.1% Tween-20 (Sigma) (TBS-T) for 1 hour 
at room temperature.  After a series of washes in TBS, the membrane was incubated 
with primary antibody overnight at 4°C.  Antibodies (see 2.6) were dissolved in 5% 
Marvel and TBS-T.  The membrane was subsequently washed and incubated with 
goat anti-mouse or goat-anti-rabbit horseradish peroxidase (HRP)-conjugated 
secondary antibody (Santa Cruz, 1:5000) for 1 hour, at room temperature.  Signal 
detection involved incubating the membranes with ECL-plus reagent (GE Healthcare) 
for 1 minute, then placing the membrane against a radiographic film before 
developing at different exposure times. 
 
To control for variation in protein loading, Western blots were stripped prior to re-
probing with anti-actin (clone 4 MAB1501, Millipore, UK) at a dilution of 1:2000. 
Secondary antibodies were administered at a dilution of 1:1000 (goat anti-rabbit Ig-
HRP, Dako, UK) or 1:2000 (rabbit anti-mouse Ig-HRP, Dako, UK) for 1 hour RT.  
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2.5 Immunohistochemistry 
 
For immunofluorescence analysis, cells in culture were washed three times in PBS, 
and fixed for 10 minutes with 4% paraformaldehyde.  Coverslips were then dipped 
and rinsed three times in PBS again.  0.1% Triton X100 was applied to coverslips for 
10 minutes at room temperature before washes were repeated.  Cells were blocked for 
one hour, in PBS and 2% BSA, before removing and adding primary overnight at 
room temperature.  Coverslips were washed 3 x 5 minutes in PBS.  Detection was 
achieved using goat anti-rabbit or goat anti-mouse antibody (Alexa) at a dilution of 
1:400; incubated for 1hr at room temperature.  Three, 5 minute washes were followed 
by nuclear counterstaining with Hoechst 33342 100ng/ml.  After two washes slides 
were mounted with CityFluor. 
 
 
2.6 Antibodies 
 
Table 2.3: Antibodies 
Tuj-1 anti-neuron-specific Class III β-tubulin mouse monoclonal was kindly donated by 
Tim Cowen. 
Antibody Supplier Concentration (!L) 
Apparent 
size 
(kDa) 
Expected 
size 
(kDa) 
Method 
mouse  
anti-hsp70 Enzo 
1/1000 or  
1/50 & 1/100 ~62 70 
Western/ 
Immuno 
rabbit  
anti-TrkA 
Chemicon 
International 1/1000 ~98  Western 
rabbit  
anti-sortilin Abcam 1/2000 ~90 95 Western 
mouse  
anti-actin 
Millipore, 
UK 1/2000 ~40 38 Western 
rabbit  
anti-NRAGE 
polyclonal 
Upstate 1/500 ~90 96 Western 
anti-Tuj1  1/1000   Immuno 
rabbit 
anti-GFAP 
polyclonal 
Dako 1/1000   Immuno 
rabbit 
anti- 
Neurofilament 
Chemicon 
International 1/1000   Immuno 
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2.7 Live/Dead Glial Assay 
 
Primary aged SCG neurons, using the cell culture method above (2.2) were plated at 
300/well and cultured for 48 hrs.  To determine the ratio of live/dead glial cells, a 
Molecular Probes Live/Dead Viability/Cytotoxicity assay kit (L-3224) was used.  
Solutions were made up immediately prior to use with 1ml solution added to each 
well required for counting.  Cells were incubated for 15 minutes at 37oC.   
 
The two-colour fluorescence assay confirms the viability of cells through the 
determination of intracellular esterase activity and plasma membrane integrity.  Live 
cells are distinguished by the presence of intracellular esterase activity, which is 
verified by the enzymatic conversion of cell-permeant polyanionic dye calcein AM  
into calcein to produce a uniform green fluorescence (ex/em ~495 nm/~515nm).  In 
contrast, ethidium homodimer-1 (EthD-1) enters cells with damaged membranes, and 
undergoes 40-fold enhancement of fluorescence after binding to nucleic acids, thereby 
producing a bright red fluorescence in dead cells (ex/em ~495nm/~635 nm).  This 
does not occur in live cells because EthD-1 is excluded by the intact plasma 
membrane.   
 
 
2.8 NRAGE siRNA delivery  
 
The NRAGE sequence consisted of a 22 nucleotide (22nt) duplex with disulphide 
overhang, as described and validated by (Matluk et al., 2010).  The NRAGE siRNAs 
(Dharmacon, UK) were chemically synthesised and received in lyophilised, pre-
annealed duplex form.  siRNA pellets were resuspended in sterilised RNAse-free 
water then incubated for 1 hour at room temperature before linkage to the vector 
peptide Penetratin-1 (Pen-1) (Davidson et al., 2004) (MP Biomedicals, UK) in non-
reducing conditions. The final concentration of the solution was 80#M and kept at 4oC 
until use. 
 
Sense sequence 
S-S.G.G.C.U.U.G.G.A.A.U.G.A.C.A.C.U.A.C.U.U.U 
Antisense sequence 
A.G.U.A.G.U.G.U.C.A.U.U.C.C.A.A.G.C.C.U.U 
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A control sequence was generously donated by Elena Ribe Garrido.  For delivery of 
siRNA, cells were cultured as described earlier (2.2).  siRNA was heated to 650C for 15 
minutes then 1 hour at 37oC, 5% CO2.  At the time of plating, NRAGE siRNA and 
control siRNA containing Pen-1 was administered at 80nM. 
 
 
2.9 Statistical analysis  
 
Statistical analysis was performed using the Chi squared χ2 test using GraphPad 
Prism 5.0, which evaluates the statistical significance of differences in frequencies of 
classes (e.g. live and dead) between samples.  All comparisons were analysed within 
one experiment, i.e. limited to treated and untreated control populations of cells 
derived from a single preparation of neurons.  Experiments were repeated in 
triplicate, and differences were not deemed to be significant unless there was 
concordance between the different experiments.  
 
Quantitative analysis of western blot data was performed by densitometry of entire 
bands, with subtraction of background immediately adjacent to the band.  The ratios 
of background-subtracted desired protein and actin signals from samples analysed on 
the same blot were analysed by the Mann-Whitney test using GraphPad Prism 5.0 to 
determine any significant difference in the relevant protein, with the threshold value 
p=0.05.  
 
Quantitative immunofluorescence was performed as previously described (Al-Shawi 
et al., 2008); statistical analysis was executed by the Mann-Whitney test using 
GraphPad Prism 5.0, with the threshold value p=0.05.  
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3.1 The effect of JNK inhibition on the growth and survival of 
ageing peripheral neurons
		
	 	
  Results  
	
	 	
58 
3.1.1 Introduction 
 
 
 JNK activation and regulation 3.1.1.1
 
JNKs are required for both neuronal apoptosis and axon degeneration, in response to 
stress, but also have the ability to regulate neuronal growth and homeostasis (Chang 
et al., 2003; Bjorkblom et al., 2005).  Therefore, signalling diversity is vital for the 
execution of a number of different functions (see Introduction 1.3.3). 
While the focus of this study remains with neurotrophic-induced JNK signalling in 
adult and aged peripheral neurons, it is important to understand that activation of 
JNK can be prompted by a response to many stimuli.  Also termed stress-activated 
protein kinases (SAPKs), JNKs respond to external stresses such as heat shock (Adler 
et al., 1995), UV irradiation (Pulverer et al., 1991; Derijard et al., 1994) and osmotic and 
redox stress (Bogoyevitch et al., 1995).  JNKs can also be activated during 
physiological responses via activation of G-protein-coupled receptors (GPCRs) and 
the non-canonical Wnt pathway (Marinissen and Gutkind 2001; Pandur et al., 2002).    
 
 JNK-mediated cell death in developing peripheral neurons	3.1.1.2
 
In cultured neonatal sympathetic neurons, NGF withdrawal causes p75NTR-mediated 
neuronal apoptosis via JNK-dependent c-Jun activation (Estus et al., 1994; Ham et al., 
1995; Eilers et al., 1998; Bruckner et al., 2001).  To elicit this signal, p75NTR-induced 
activation of JNK requires receptor interacting proteins e.g. NRIF (Linggi et al., 2005), 
TRAF6 (Yeiser et al., 2004), Rac (Harrington et al., 2002), NRAGE (Salehi et al., 2002).   
 
Once activated, JNK binds the NH2- terminal activation domain of the c-Jun 
transcription factor (Adler et al., 1992; Hibi et al., 1993) and also binds activating 
transcription factor (ATF2).  Activated c-Jun/ATF2 dimers subsequently regulate the 
Jun promoter, which increases c-Jun levels and mediates cell death (Herr et al., 1994; 
Ham et al., 1995; Yuan et al., 2009).  This prompts the expression of pro‐apoptotic 
genes Dp5, Bim and Puma, which are apoptotic facilitators of the Bcl‐2 protein family 
(Harris and Johnson 2001; Whitfield et al., 2001; Putcha et al., 2003; Besirli et al., 2005; 
Jacobs et al., 2005; Wyttenbach and Tolkovsky 2006; Kristiansen et al., 2011).  
Induction of these BH3 domain-only proteins activate the intrinsic apoptotic cascade 
(Chen and Tan 2000; Tournier et al., 2000), and involves the release of several pro-
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apoptotic factors, including cytochrome c and SMAC, through the permeabilisation of 
the outer mitochondrial membrane.  These factors co-operate to activate initiator 
caspase-9, which mediates the cleavage of several cellular targets during apoptosis.  
In SCG neurons, trophic deprivation stress and activation of the p75NTR receptor leads 
to BAX‐dependent release of cytochrome c and apoptotic death (Putcha et al., 2003).  
Although the death function of these proteins is executed in the cytoplasm, the initial 
trigger for the rapid induction of BH3‐only proteins occurs in the nucleus and is JNK- 
dependent (Putcha et al., 2003).   Importantly, the role of c-Jun in mediating JNK‐
dependent neuronal death has not been demonstrated across all models (Okuno et al., 
2004; Bjorkblom et al., 2008; Ruff et al., 2012) suggesting JNK is not always involved in 
c-Jun‐mediated death and conversely, that c-Jun is not always activated by JNK. 
 
Additional gene targets for JNK have been discovered in developing sympathetic 
neurons deprived of NGF, which suggests a completely independent regulatory 
pathway to JNK-c-Jun in the process of apoptosis.  These include the ER stress 
pathway genes Trib3 (tribbles homologue 3), Ddit3 (DNA damage‐inducible 
transcript 3) and Txnip (thioredoxin interacting protein), among others (Kristiansen et 
al., 2011).  In cultured developing sympathetic neurons, the Rac GTPase target POSH 
has also been associated with JNK-induced neuronal death through NGF deprivation 
(Tapon et al., 1998; Xu et al., 2003). 
 
 JNK-mediated growth 	3.1.1.3
 
Experiments concerning JNK actions on neurite outgrowth have largely been 
performed in PC12 cells (Heasley et al., 1996; Eilers et al., 1998; Waetzig and 
Herdegen 2003a; Eom et al., 2005), which are ‘‘neuronally’’ differentiated by NGF and 
compounds or constructs that simulate NGF treatment (Yao et al., 1997; Goodman et 
al., 1998).  
 
Through the use of pan-JNK inhibitors (SP600125) and transfection with dominant 
negative JNK mutants, which substantially decrease sprouting (Kita et al., 1998; 
Giasson et al., 1999; Waetzig and Herdegen 2003a), NGF-induced neuronal growth in 
PC12 cells was shown to display JNK dependency (Kobayashi et al., 1997; Goodman 
et al., 1998).  Further studies confirmed that all JNK isoforms are involved in neurite 
outgrowth (Yang et al., 1998; Waetzig and Herdegen 2003a; Waetzig and Herdegen 
2003b; Waetzig and Herdegen 2005), although JNK3-dependent NGF-induced 
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sprouting in PC12 cells requires transfection of exogenous JNK3 (Waetzig and 
Herdegen 2003b).  The idea that neuritogenesis is supported by all JNK isoforms is 
reinforced by studies in primary hippocampal and cortical neuron cultures (Eminel et 
al., 2008), however these experiments were not performed in the presence of NGF.    
 
Cell culture studies have further reported a high enrichment of activated JNK in 
axons; signifying a role for JNK in axonogenesis.  Additional studies indicate JNK 
dependency in neural migration, polarity, and axon guidance, although once again, 
experiments have predominantly focused on central neurons during early 
development, and it is not known whether this is NGF-induced (Coffey et al., 2000; 
Oliva et al., 2006; Tararuk et al., 2006; Qu et al., 2013).  Recently, Qu et al., (2013) 
demonstrated that JNK signalling is required for Netrin signalling (axon guidance) in 
the developing nervous system.  Netrin-1 increased JNK1, not JNK2 or JNK3, activity 
in the presence of Netrin receptors. 
 
Cytoplasmic JNK substrates like doublecortin (DCX), microtubule assembly-
promoting proteins (MAP1B, MAP2) and the heavy unit of the neurofilament protein 
(NFH) are also important for mediating neurite elongation, as observed in cell culture 
studies of the developing brain (Kawauchi et al., 2003; Waetzig and Herdegen 2003a; 
Gdalyahu et al., 2004).  Again, JNK1 has been singled out to have a more 
distinguished role in these physiological processes (Chang et al., 2003; Kawauchi et 
al., 2003; Bjorkblom et al., 2005).  In neural migration, Westerlund et al., (2011) 
discovered that JNK phosphorylation of SCG10, a stathmin brain-derived JIP, is a key 
mechanism that controls the rate of neuronal cell movement in corticogenesis.  This 
process is also facilitated by JNK1, unlike after NGF deprivation in developing 
sympathetic neurons, where phosphorylation of SCG10 is controlled by JNK3 
(Neidhart et al., 2001). 
Further downstream, while c-Jun is involved in JNK-dependent cell death, it is also 
necessary for the formation of neurites (Leppa et al., 1998; Dragunow et al., 2000; 
Levkovitz and Baraban 2002).  Overexpression of c-Jun mimics some effects of NGF 
and leads to neurite outgrowth (Leppa et al., 1998; Dragunow et al., 2000).  However, 
c-Jun overexpression-mediated differentiation does not result in the entire range of 
differentiation characteristics displayed in NGF-treated PC12 cells (Dragunow et al., 
2000); suggesting that c-Jun-triggered gene expression is sufficient for sprouting, but 
not for a complete differentiation process.  
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It is important to mention that the nuclear activity of JNKs is different in neuronal cell 
lines and primary cells: in PC12 cells, NGF-induced neuritogenesis is substantially 
mediated by phospho c-Jun (Leppa et al., 1998; Dragunow et al., 2000); in primary 
central neurons, phosphorylation of c-Jun is down-regulated despite an increasing 
activity of JNK (Coffey et al., 2000; Eminel et al., 2008). 
Overall, NGF promotes a multitude of actions on peripheral axons in vitro including 
elongation, branching, growth cone turning responses, and changes in growth cone 
morphology (Gallo and Letourneau 1998; Markus et al., 2002), all of which may be 
required for NGF-mediated innervation of final target tissues in vivo.  To facilitate 
these processes, several studies in PC12 cells propose that JNK works in tandem with 
kinases, PI3K and ERK1/2, in the complete response to NGF in neuritogenesis 
(Kobayashi et al., 1997; Kita et al., 1998; Zentrich et al., 2002; Waetzig and Herdegen 
2003a; Xiao and Liu 2003).  Research indicates that PI3K induces sprouting through 
the activation of JNKs, whereas for neurite outgrowth, ERK1/2 and the JNKs signal in 
concert (Kobayashi et al., 1997; Kita et al., 1998; Zentrich et al., 2002; Waetzig and 
Herdegen 2003a; Xiao and Liu 2003).  It has been further suggested that ERK1/2 
trigger the early stages of sprouting, whereas JNKs are responsible for later phases of 
neurite formation and stabilisation (Xiao and Liu 2003).  
 
 JNK signalling in ageing and after injury 3.1.1.4
 
As previously discussed (Introduction 1.4), nerve injury triggers a number of changes 
within the affected neurons and surrounding non-neuronal cells that ultimately result 
in successful target re-innervation or cell death, though this is delayed in ageing.  The 
morphology of sympathetic neurons, axons and dendrites, their targets undergoing 
atrophy in ageing (Gavazzi et al., 1992; Gavazzi and Cowen 1993a), and the benefits 
of NGF in these areas, have been significantly researched (Andrews and Cowen 
1994b; Thrasivoulou and Cowen 1995; Cowen et al., 1996; Cowen et al., 1997).  
Although regeneration of aged sympathetic neurons can occur in the absence of NGF 
(Gloster and Diamond 1992), collateral sprouting is NGF-dependent and can be 
affected in ageing due to an impaired responsiveness to NGF (Kuchel 1993; Gavazzi 
1995).  The precursor to NGF, proNGF, has also displayed neurotrophic properties in 
aged sympathetic cultures (Fahnestock et al., 2004; Al-Shawi et al., 2008), however 
further studies are required to determine whether this is JNK-dependent (Results 
3.3). 
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While further studies are required in sympathetic neurons, JNK actions have already 
been identified in the process of regeneration through in vivo studies on sensory 
neurons, derived from adult rodents (Kenney and Kocsis 1998; Barnat et al., 2010; 
Ruff et al., 2012).  In the study undertaken by Ruff et al., (2012), c-Jun is shown to 
promote peripheral nerve regeneration after facial nerve cut in 8-10 week old  mice, 
although it is unknown whether this is NGF-dependent.  In vivo and in vitro studies 
by Lindwall et al., (2004), also on rat sensory neurons, reported that JNK inhibition 
substantially reduces axonal outgrowth, c-Jun activation and ATF-2 induction, 
without affecting survival.  
 
As mentioned, neuritogenesis is reliant on JNK2 and JNK3, but not JNK1 during the 
axonal regeneration of adult mouse DRG.  However, sustained neurite elongation 
requires JNK1 and JNK2.  JIP1 is also involved in the initiation and extension stages; 
Barnat et al., (2010) discovered that JIP1, as well as activated JNKs, were present in the 
cytoplasm of sprouting or regenerating axons, suggesting a local action on 
cytoskeleton proteins.  In the same study, JNK inhibition-induced neurite retraction 
was also shown to involve MAP1B, an important microtubule regulator involved in 
the elaboration and maintenance of axonal and dendritic processes.  Further reports 
revealed that JNK1 and JNK2 control the phosphorylation state of MAP1B.  Therefore, 
signalling by individual JNKs is differentially implicated in the reorganisation of the 
cytoskeleton, and neurite regeneration. 
 
 Cytoskeletal functions	3.1.1.5
 
It has become clear that the role of JNKs in neurite elongation and nerve fibre 
regeneration is dependent on the stability and reactive flexibility of the cytoskeleton.  
A complex network of interlinking tubules and filaments, the cytoskeleton has a 
heavy influence on the intracellular transport of vesicles by molecular motor proteins 
such as kinesins, dyneins, and myosins.  Studies by Middlemas et al., (2003) in 
peripheral neurons show that not only is JNK localised to nerve axons, but it is 
transported both anterogradely and retrogradely.  Further investigation by Cavalli et 
al. (2005), in the sensory neurons of adult rodents, demonstrated that after nerve 
injury, JNK is activated locally as part of a retrograde axonal damage signal and that 
Sunday Driver (syd), a receptor protein homologous to JIP3 (Bowman et al., 2000), 
interacts with both JNK3 and kinesin-I as a scaffolding protein.  In turn, this may 
mediate both the anterograde and retrograde transport of JNK via interaction with 
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kinesin-I and dynactin/dynein, respectively.  As anterograde transport is disrupted 
and retrograde transport increases following axotomy-induced JNK3 activation, it is 
believed that JNK3 acts as a surveillance sensor that responds to stress by altering 
motor transport.  
It has been suggested that distinct outcomes of positive and negative influences on 
neuronal migration may be attributed to opposing functions of nuclear and cytosolic 
JNK (Bjorkblom et al., 2008).  The same group further propose that simultaneous 
knockdown of all three JNK isoforms is not enough to provide neuroprotection.  
Bjorkblom et al. (2008) argue that JNK-dependent death responses are location 
specific rather than isoform specific, and that JNK inhibition in the cytosol does not 
protect from trophic withdrawal-induced death in early development, but it does in 
the nucleus.   
 
 Drug Therapy and Experimentation	3.1.1.6
 
In order to understand the functional importance of JNK, researchers have benefited 
from molecular cloning, and experiments to decipher the structural properties of the 
different JNK proteins (Xie et al., 1998; Heo et al., 2004; Shaw et al., 2008).  These, 
combined with several in vivo genetic disruption methods and screenings to identify 
small molecule ATP-competitive inhibitors such as SP600125 (anthrax(1,9-cd) 
pyrazole (2H)-0ne) (Bennett et al., 2001) have improved our understanding into the 
role of JNKs.  Pan-JNK inhibitors, such as cell permeable peptides D-JNK-1 (XG-102) 
(Bonny et al., 2001), a retroinverso peptide derived from the inhibitory region of JIP-1, 
and SP600125 (Bennett et al., 2001) (JNK1,2 and 3; IC50 0.11, 0.11, 0.15#M 
respectively) have been used extensively in research for over a decade. 
D-JNKI-1 was found to be neuroprotective during ischemia (stroke model) (Vaslin et 
al., 2011) and the kainic acid-induced seizure model in rat (Spigolon et al., 2010).  The 
JNK3 pool in mitochondria was suggested as the D-JNKI-1 target responsible for 
neurodegeneration in the seizure-induced model in the hippocampus (Zhao et al., 
2012).  D-JNK1-1 has also been shown to have protective effects in animal models of 
AD (Ballatore et al., 2007; Tran et al., 2012).  
More recently, it was demonstrated that p38α, and not JNK, was a potential target of 
D-JNKI-1 in vivo (Kaoud et al., 2011).  Part of the same MAPK family as JNK, p38 is 
involved in maintaining synaptic plasticity in the CNS, and so selectivity against this 
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kinase could be misleading.  Pan-JNK inhibitor, SP600125, is selective against p38b 
(Bennett et al., 2001) and is neuroprotective in transient brain ischemia/reperfusion-
induced neuronal cell death in rat hippocampus (Guan et al., 2005).   
SP600125 has also been found to provide neuroprotection in neurodegenerative 
diseases (0.3#M), such as HD (Reinhart et al., 2011) and a brain slice-based model of 
AD (Braithwaite et al., 2010).  In adult rat, 10#M SP600125 strongly reduces JNK-
dependent outgrowth of sensory nodose ganglion and DRG neurons while at 200#M, 
neurite outgrowth is completely blocked (Lindwall et al., 2004; Barnat et al., 2010).  
This can also be observed in sympathetic neurons (Lindwall and Kanje 2005).  
SP600125 inhibition or transfection with dominant negative JNK mutants also 
influences a reduction in NGF-induced sprouting in PC12 cells (Kita et al., 1998; 
Giasson et al., 1999; Waetzig and Herdegen 2003a).  Indirect JNK inhibition through 
CEP-1347, a selective mixed lineage kinase (MLK) inhibitor (Xu et al., 2001), in 
cultured mouse sympathetic neurons, diminished phosphorylation of c‐Jun and 
apoptotic death in response to NGF deprivation (Bruckner et al., 2001).   
 
The notion that improved neuroprotection could be achieved through selective 
inhibition of JNK isoforms has further driven the search for isoform-specific inhibitors 
in the brain (Coffey et al., 2002; Brecht et al., 2005).  In ageing, there is a lot of interest 
surrounding the discoveries of neuroprotection in JNK3 KO animals.  In excitotoxic 
and ischemic models in the brain, JNK3 has been found to play a major role (Brecht et 
al., 2005).  In 2003, in the attempt to find efficient and innocuous compounds to target 
JNK3, four crystal structures of JNK3 in complex with 2 different classes of inhibitors 
were reported.  This formed a platform upon which modifications could be made in 
order to tackle issues such as potency and selectivity of inhibitors used.  Early drug 
discovery has been reviewed by Siddiqui and Reddy (2010), and any inhibitors 
identified prior to 2010 have been reviewed by Bogoyevitch and Arthur (2008); 
Bogoyevitch et al., (2010).  Each review promotes the idea that isoform-specific 
inhibition of JNK and, more specifically, the development of a selective JNK3 
inhibitor is of paramount importance for the treatment of neurodegenerative diseases 
(Resnick and Fennell 2004). 
 
 
		
	 	
  Results  
	
	 	
65 
3.1.2 Aims 
 
While the effect of JNK inhibition on survival and growth has been monitored in 
adult sensory neurons following injury, little is known about the effect in adult 
sympathetic neurons, let alone aged sympathetic neurons. 
The hypothesis that will be addressed in this section is that JNK is important for the 
survival and growth of explanted SCG neurons from young adult and aged mice. 
The effect of JNK inhibition on SCG neurons will be monitored in culture, but it will 
be important to observe whether there are differences between young adult and 
ageing neurons.  The addition of isoform-specific inhibitors will also seek to establish 
whether specific JNK isoforms are important for different neuron survival and 
growth responses.  For inhibitors used, please see Table 2.2 p42. 
 
  
		
	 	
  Results  
	
	 	
66 
3.1.3 Results 
 
 JNK inhibition in young adult and aged SCG neurons 3.1.3.1
 
To study the effect of JNK inhibition on peripheral neurons of young adult and aged 
mice, pan-JNK inhibitors were applied to dissociated SCG sympathetic neurons in 
culture.  Two inhibitors with different modes of delivery were administered: JNK 
inhibitor II, an ATP competitive inhibitor of JNK and JNK inhibitor III, a cell 
permeable peptide, which disrupts the c-Jun/JNK interaction.   
 
Initially, pan-JNK inhibitor, JNK Inhibitor II (SP600125 as it is more commonly 
known), was administered at 10#M to NGF (0.4nM)-treated and untreated control 
SCG neuron cultures derived from young adult and aged mice.   
 
JNK Inhibitor II did not significantly affect survival, either in the presence or absence 
of NGF (Fig 3.1).  However, neurite outgrowth of SCG neurons isolated from both 
young adult and aged mice was significantly reduced.  The proportion of growing 
neurons compared to control cultures containing NGF and JNK inhibitor II 
decreased by 90%.   
As the effects of JNK inhibition on survival were similar with the addition of NGF to 
culture (Fig 3.1), any further experiments shown are confined to neurons cultured in 
the presence of NGF. 
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Figure 3.1: Effect of JNK Inhibitor II on survival and neurite outgrowth of 
cultured young adult and aged SCG neurons 
 
Relative survival (filled bars) and growth (open bars) of neurons from young adult and aged 
mice is shown after culture under the conditions indicated.  For clarity, survival was 
normalised to the control cultures; growth was normalised to NGF (0.4nM)-containing control 
cultures.  JNK inhibitor II (10#M) did not significantly affect the survival, but did reduce the 
proportion of growing neurons (p<0.0001; n=300) in untreated and NGF-treated young adult 
and aged SCG neuron cultures.  
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To observe whether different mechanisms of action affect the outcome of JNK 
inhibition in aged mice, JNK inhibitor III was administered in a separate experiment.  
Following the administration of JNK inhibitor III in cell culture, similar results were 
observed to previous experimental cultures containing JNK Inhibitor II, whereby 
JNK inhibitor III did not affect the survival of young adult and aged SCG neurons 
but it did restrict neuritogenesis (Fig 3.2).  
 
In Fig 3.2, pan-JNK inhibitor III reduced the proportion of growing NGF-treated 
aged SCG neurons by approximately 70% relative to NGF control.  The proportion of 
growing NGF-treated SCG neurons was reduced by 40%, relative to control. 
 
 
 
 
 
Figure 3.2: Effect of JNK Inhibitor III on the survival and neurite outgrowth 
of cultured young adult and aged SCG neurons  
 
JNK inhibitor III (10#M) did not significantly affect the survival of NGF-treated young adult 
and aged SCG neurons, but significantly reduced the proportion of growing NGF-treated 
neurons in culture (p<0.0001; n=300). 
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To delve deeper into JNK dependency, specific inhibitors were administered to 
determine whether any specific JNK isoform has a greater impact on survival and 
neuritogenesis of SCG neurons derived from young adult and aged mice.  JNK 
inhibitor VIII (inhibits JNK 1+2 more effectively that JNK 3) and JNK inhibitor IX 
(inhibitor of JNK 2+3) were administered at 10#M to NGF-treated SCG neurons from 
young adult and aged mice.   
 
As expected, neuronal survival was not significantly affected by the addition of JNK 
inhibitor VIII and IX to NGF-treated cultures of young adult and aged SCG neurons 
(Fig 3.3), and a similar level of survival was observed compared with control-
untreated cultures. 
 
However, consistent with other JNK inhibitors used in this study, JNK inhibitor VIII 
and JNK inhibitor IX significantly reduced NGF-induced neurite outgrowth in 
young adult and aged cultured SCG neurons, although JNK inhibitor IX was much 
more effective. 
 
JNK Inhibitor VIII reduced the proportion of growing NGF-treated young and aged 
SCG neurons by approximately 50% relative to NGF control.  Whereas neurite 
outgrowth of SCG neurons is completely abolished in the presence of JNK inhibitor 
IX in both young adult and aged neurons, with double the reduction induced by JNK 
inhibitor VIII.   
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Figure 3.3: Effect of JNK inhibitor VIII and IX on the survival and neurite 
outgrowth of cultured young adult and aged SCG neurons 
 
JNK inhibitor VIII and IX had no significant effect on the survival of NGF-treated SCG 
neurons of young adult and aged mice but significantly reduced the proportion of growing 
NGF-treated (0.4nM) SCG neurons derived from young adult mice, (p<0.0001; n=300) and 
aged mice (p<0.0001; n=300).  JNK Inhibitor IX was more effective than JNK Inhibitor VIII and 
completely halted any neurite outgrowth  (p<0.0001; n=300). 
 
 
 
AEG3482, a cell permeable imidathiadiazole, was discovered, out of 17,000 natural, 
synthetic and semi-synthetic compounds, to reduce p75NTR/NRAGE/JNK-mediated 
cell death of PC12 cells, following NGF withdrawal (Salehi et al., 2006).  As an indirect 
JNK inhibitor, AEG3482 works by activating HSP90, which subsequently induces 
HSF-1 dependent expression of HSP70 mRNA, an anti-apoptotic protein that binds 
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and deactivates JNK.  Therefore, it was relevant to explore the effect of this compound 
on survival and neurite outgrowth of young adult and aged dissociated SCG neurons.   
 
Fig. 3.4, indicates that AEG3482 did not have an impact on neuronal survival in both 
young adult and aged NGF-treated SCG neurons in culture.  However, AEG3482 had 
a restrictive effect on NGF-induced neurite outgrowth in young adult and aged 
cultured SCG neurons.  In Fig 3.4, AEG3482 reduced the proportion of growing NGF-
treated neurons by 80% in young adult SCG cultures and 70% in aged SCG cultures.   
 
It is not possible to compare the two experiments because each culture requires 
different preparation so there may be variability in the culturing of neurons from 
mice of different ages, however, the key point is that the same result is observed in 
young adult and aged cultures. 
 
 
 
 
 
Figure 3.4: Survival and neurite outgrowth of AEG3482-treated cultured 
young adult and aged SCG neurons 
 
AEG3482 (40#M) had no significant effect on the survival of NGF-treated SCG neurons of 
young adult and aged mice but significantly reduced the proportion of growing NGF-treated 
SCG neurons derived young adult mice (p<0.0001; n=900) and aged mice (p<0.0001; n=900). 
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Figure 3.5 gives a representative picture of how the neurite outgrowth of individual 
neurons was affected following the administration of different JNK inhibitors.  NGF 
clearly had a positive effect on neurite outgrowth of aged neurons in culture (A).  
JNK inhibitor II, III, VIII and AEG3482 (B-E) all restrict the proportion of growing 
cultured aged neurons, while JNK inhibitor IX (F) completely eliminates any NGF-
induced neurite formation.  Similar results were observed in young adult cultures 
(results not shown). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5: Representative photomicrographs of NGF-treated neurons in the 
presence of various JNK inhibitors in SCG cultures derived from aged mice. 
 
A characteristic growing neuron cultured under NGF-treated control conditions.  (B) NGF and 
JNK inhibitor II – treated culture, showing two living neurons with no neurite outgrowth and 
a glial cell (white arrow).  (C) A neuron growing in the presence of NGF and JNK inhibitor III; 
the white arrow indicates a glial cell with extensions. (D) Neurons cultured with NGF and 
AEG3248, two of which show no growth.  (E) Neurons cultured with NGF and JNK inhibitor 
VIII, one of which is dead (black arrow); nearby glial cell (white arrow).  (F) Neurons cultured 
with NGF and JNK inhibitor IX, showing the typical absence of any significant growth.      
Scale bar = 100#m 
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 HSP70 Immunohistochemistry and Western Analysis 3.1.3.2
 
In PC12 cells, AEG3482 indirectly up-regulates the expression of anti-apoptotic 
protein HSP70, which peaks between 16-30 hours after AEG3482 administration 
(Salehi et al., 2006).  HSP70 also has the ability to restrict neuritogenesis; the use of 
HSP70 inhibitor, KNK437, in PC12 cells induced neurite outgrowth in the absence of 
stress stimulation (Koike et al., 2006).   
 
As there was no difference in the survival and growth of neurons across ages in 
AEG3482-treated SCG cultures, young adult neurons were used to visualise HSP70 
levels.  Immunohistochemistry was carried out on fixed cultures, 21 hours after 
plating (Fig 3.6).  Plating density was approximately 600 cells/well and 20–30 pictures 
were taken of each condition.  Rabbit neurofilament antibody (Fig 3.6 a+d) was 
applied to distinguish neurons from glial cells.  The images are representative of each 
condition.   
At a dilution of 1:50, neurons were clearly and intensely stained with HSP70 
antibody.  The data retrieved in control neurons (Fig 3.6; A-C) was fairly consistent 
unlike data from AEG3482-treated neurons (Fig 3.6; D-F), which were slightly more 
variable.  The neuron in Fig 3.6; D was much more intensely stained than neurons in 
Fig 3.6; E + F, and this variability was observed in a number of neurons within the 
population plated, under conditions where AEG3482 was included in the medium.  
This was in contrast to the population of NGF-control treated SCG neurons, as 
represented in Fig 3.6; A-C. 
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Figure 3.6: Representative photographs of HSP70 stained control-treated and 
AEG3482-treated young adult SCG neurons  
 
(A, B and C) mouse HSP70 (mHSP70) stained SCG neurons (4 month) in NGF-treated control 
conditions.  (D, E and F) mHSP70 stained cultured young adult neurons in NGF (0.4nM) and 
AEG3482 (40#M) treated conditions (1:50).  (a/d) rabNeurofilament stained neurons (1:1000) 
corresponding to A/D panels. Neurons were fixed 21 hours after plating.  Plating density: 600 
cells per well.  Scale bar = 25#m. 
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Although the analysis of the HSP70 staining intensities displayed no significant 
difference between control-treated young adult SCG neurons and neurons cultured in 
AEG3482, relatively large error bars in (Fig 3.7) confirm that the variability was high 
between individual neurons.  The standard error for the control was 9.44 x 104.  This 
was compared to 3.2 x 105 in AEG3482-treated SCG cultures. 
 
 
 
 
 
Figure 3.7: Effect of AEG3482 on HSP70 levels in young adult NGF-treated 
SCG neurons 
 
Cultured 5-month old NGF-treated SCG neurons were fixed at 21 hours after plating.  
Neurons were stained with mHSP70 1:50.  20-30 pictures were taken of each condition then 
quantified using gray scale, as described in Materials & Methods.  There was no significant 
difference between mHSP70 intensities of NGF-control treated neurons and neurons treated 
with NGF + AEG3482 (p=0.06).  Standard error of Control: 9.44 x 104, AEG3482: 3.2 x 105. 
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To observe if there was a difference in HSP70 levels in sympathetic ganglia of young 
adult and aged mice, western analysis (Fig 3.8) was conducted on pooled SCG 
samples.  Each lane represents a pool of six SCGs from three mice.  Under conditions 
where noxious stimuli are absent, results indicated that there was no significant 
difference in HSP70 levels between age-groups. 
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Figure 3.8: Western blot analysis of SCG lysates of aged and young adult mice 
 
(A) HSP70, 62kDa (B) Actin, (C) There was no significant difference in HSP70 levels, 
normalised to actin, of SCG cells from old  (24-36 months) and young adult (3-6 months) mice 
p=0.70.  For each age-group, n=6, non-parametric t-test (Mann-Whitney).  SCG lysates are 
represented by Om –  old males, Of –  old females, Ym – Young males, Yf - Young females.  
Con – brain tissue.   
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3.1.4 Discussion 
 
The results from this chapter demonstrated that, while the survival of cultured young 
adult sympathetic neurons was unaffected by JNK inhibition, neurite outgrowth was 
reduced.  The same pattern was also observed in aged SCG neurons suggesting that 
sympathetic responsiveness to JNK signalling is not impaired in ageing and correlates 
with previous studies that ageing neurons are not dependent on NGF for survival, 
but are for growth. 
 
The application of pan-JNK inhibitors, JNK inhibitor II and III, which work through 
different modes of inhibition, ATP-competitive inhibition of JNK or disruption of the 
c-Jun/JNK interaction respectively, were able to produce similar results in short-term 
culture.  Another compound used, which inhibits JNK indirectly, and was found to 
have an impact on neonatal neuron survival, is AEG3482.  At 40#M, AEG3482 
reduced p75NTR/NRAGE/JNK-mediated apoptosis of neonatal sympathetic neurons 
following NGF withdrawal (Salehi et al., 2006).  When the same concentration was 
administered to NGF-treated young adult and aged cultured SCG neurons, in this 
study, AEG3482 did not affect survival.  Furthermore, results displayed a similar 
effect on neurite outgrowth as was observed following the addition of JNK inhibitor 
II and III; while there was no effect on survival, it was clearly evident that the 
AEG3482 strongly inhibits NGF-induced neurite outgrowth of sympathetic neurons 
from young adult and aged mice.  
 
In previous studies, AEG3482 indirectly up-regulates the expression of anti-apoptotic 
protein HSP70, which peaks between 16-30 hours after AEG3482 administration 
(Salehi et al., 2006) and rescues cells from p75NTR -induced death.  As cultured young 
adult and  neurons are not dependent on NGF for survival, and as AEG3482 had no 
affect on the survival of these NGF-treated neurons in culture, it was proposed that 
HSP70 levels were not up-regulated.  The other explanation was that HSP70 levels 
increased, but contributed to the restriction of neurite outgrowth instead.  This had 
been previously observed in PC12 cells where HSP70 inhibitor, KNK437, induces 
neurite outgrowth (Koike et al., 2006).  In that model, HSP70 RNA levels are inhibited 
and neurite outgrowth is promoted, in the absence of stress stimulation.  This process 
was blocked by the introduction of growth-signalling pathway inhibitors for ERK, 
p38 MAP kinases and glycogen synthase kinase 3β.   
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To assess whether HSP70 levels had increased in SCG neurons, HSP70 
immunohistochemistry was performed on fixed young adult neurons in culture.  
After 21 hours, HSP70 levels did not change significantly in the presence of AEG3482.  
This result suggests that AEG3482 could be working via a different mechanism, 
independent of HSP70, to restrict neurite outgrowth and that there was no effect on 
survival because HSP70 was not up-regulated.  The other possibility is that HSP70 
levels were elevated but this was not visualised.  
Even though there was no significant increase in HSP70 levels of aged SCG during 
immunohistochemical studies, there was increased variability.  This was observed in 
the standard error of HSP70 staining intensities, in NGF and AEG3482-treated young 
adult SCG cultured neurons, which was extremely high when normalised against 
control.  This could be attributed to the different sub-populations of SCG neurons 
present in cell culture, which project to different targets, e.g. iris and cerebral vessels, 
and exhibit varying degrees of vulnerability in ageing. 
 
Western blot data further demonstrated that levels of HSP70 were not found to 
significantly change between young adult and aged mice in sympathetic neurons.  
However, it is important to note that this data also includes protein expression in 
non-neuronal cells; HSP70 is also present in glia.  It should also be taken into account 
that the HSP70 subfamily of HSP’s have at least seven members in the mouse, 
including both constitutive and inducible forms (Esser et al., 2004).  HSP’s contain 
highly conserved N-terminal ATP-ase and C-terminal protein binding domains, so 
some cross-reactivity with the antibody may have occurred. 
 
To explore the effects of JNK inhibition further, isoform-specific inhibitors were 
administered in culture to determine whether the survival and growth of NGF-
treated SCG neurons is dependent on one particular JNK isoform or a combination of 
the three isoforms JNK1, 2 and 3.  JNK inhibitor VIII and JNK inhibitor IX similarly 
showed no effect on neuronal survival of NGF-treated young adult and aged cultured 
SCG neurons but did inhibit neurite outgrowth.  JNK inhibitor IX was highly 
effective at reducing neurite outgrowth in cultured SCG neurons and completely 
abolished neuritogenesis at a concentration of 10#M.  In fact, JNK inhibitor IX and 
AEG3483 exhibit similar responses when it comes to the neuronal survival in aged 
SCG neurons and the effects on glial processes (see next section), although they work 
through different modes of inhibition. 
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As JNK inhibitor IX inhibits JNK2 and JNK3 and JNK inhibitor VIII inhibits JNKI 
and JNK2 more effectively than JNK3, the results are consistent with JNK3 having a 
role in the neurite outgrowth of young adult and aged cultured SCG neurons.  In 
practice, it may be difficult to assign certain function to a single JNK isoform due to 
the nature of the inhibitors used.  Therefore, further experimentation with inhibitors 
that display added specificity is required to fully conclude this.  JNK-specific siRNAs 
or organelle-specific targeting might also provide a way to observe isoform-specific 
functions in aged cell culture models, which is further deliberated in the General 
Discussion(4.1.8).
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3.2 The effect of JNK inhibition on growth and survival of 
ageing peripheral glia
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3.2.1 Introduction 
 
Knowledge of the role of glia in the nervous system has improved substantially in the 
last two decades and they are now accepted as key players in practically all aspects of 
nervous system function.  Originally considered to have a limited role in supporting 
neurons, it has become clear that, without fully functioning glia, vital processes 
including the regeneration of neuronal networks, during atrophy and after injury, 
would be severely impaired.  
 
 Glia in the sympathetic system 3.2.1.1
 
Schwann cells and satellite glial cells are the non-neuronal glial cells found in 
sympathetic ganglia, and the immunoreactivity of glial cell markers in mouse and rat 
SCG has been previously described (Jessen and Mirsky 1984; Jessen et al., 1984; 
Schachner et al., 1984; Hall and Landis 1992; Okano et al., 2005).  There is a difference 
in the expression of differentiated and non-differentiated Schwann cells; Glial 
fibrillary acidic protein (GFAP) is widely expressed in situ by non-myelin forming 
glial cells but not by myelin-forming Schwann cells, including those of sympathetic, 
nerves and ganglia from adult rats (Jessen and Mirsky 1984; Jessen et al., 1984; Hanani 
2010). 
 
While Schwann cells are the most familiar non-neuronal cells in sympathetic glia, 
satellite glial cells are the most common (Hanani 2010).  Information gathered by the 
de Almeida-Leite and Arantes (2010) group produced the first report of mouse SCG 
glial cells from neonatal mice individually cultured and phenotypically characterised 
in pure primary cultures.  In their study, a few glial cells were stained with S-100 
(Schwann cell marker) and all with GFAP.  Glia were described to have a flat and 
irregular shape, two or three long cytoplasm processes, and round, oval or elongated 
nuclei, with a regular outline consistent with previous studies in human and rat 
tissues (White 1889; Chiba and Williams 1975; Madariaga-Domich and Taxi 1986; Lein 
et al., 2002).  It should be noted that not all studies agree on the composition of 
different types of glial cells in SCG.  Perez-Gonzalez et al. (2008), found whole glial 
populations stained for S-100B in microcultures of SCG from neonatal rats. 
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Earlier in this study, GFAP immunohistochemistry was used to confirm the 
differentiation between neurons and glia (Materials & Methods; Fig. 2.5).  Following 
the procedure of SCG dissociation and plating, the whole population of glia cultured 
from SCG of aged mice was weakly immunoreactive for GFAP. For the purpose of 
this study, there will be no attempt to distinguish between sub-types, however, 
current research into this field will be reviewed. 
 
Neurons are individually enclosed by a tight envelope of satellite glial cells, which are 
distinct from Schwann cells in their association with neurons.  Satellite glial cells are 
usually connected to a single neuron and wrap themselves around the soma to form a 
structural and functional unit, while Schwann cells are associated with several 
neuronal axons, forming a Remak bundle (Pannese et al., 1994; Campana 2007).  Like 
satellite glial cells, Schwann cells are laminar structures but are usually elongated 
(approx 20–400 #m) (Pannese et al., 1994).  
 
While there are plenty of studies on Schwann cells, ongoing research aims to fully 
determine the physiological role of satellite glial cells.  So far they have been found to 
play a variety of roles, including control over the microenvironment of sympathetic 
ganglia, supply of nutrients to the surrounding neurons and also to act as protective, 
cushioning cells. 
The maintenance of the characteristic phenotype of SCG neurons in culture have been 
found to be influenced by glial cells e.g. neurons in sympathetic ganglia form 
dendrites when grown in culture, but these are only extended when laminin-positive 
glia are present (Tropea et al., 1988).  Tropea et al., (1988), indicated that co-culture 
with Schwann cells allowed sympathetic neurons to form a dendritic arbor 
comparable in size to that observed in situ, and that this cell-cell interaction was 
relatively specific.  However a high concentration of non-neuronal cells were required 
to observe this effect.  Findings by Perez-Gonzalez et al. (2008), have since 
demonstrated that removing non-neuronal cells from a culture system had no effect 
on neurite outgrowth in neonatal rat SCG.  Similar results were observed in 
compartmental cell cultures of neonatal SCG neurons from neonatal mice, where glia 
were removed from the system (Howard et al., 2013).   
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 Glial responses in ageing repair and regeneration 3.2.1.2
 
Pathological changes in sympathetic ganglia following nerve injury have been 
previously investigated (Kreutzberg 1995) and studies show morphological and 
physiological changes in neurons after axotomy of the postganglionic fibres e.g. 
retraction of synaptic contacts (Matthews and Nelson 1975).  In order to reconnect 
these neuronal networks, the PNS undergoes a four-step regeneration process as 
described in the Introduction (1.4), of which glia play an important role. 
In ageing, it has been proposed that the decline in nerve regeneration after injury is 
brought about by changes in neuronal, axonal, Schwann cell and macrophage 
responses (Verdu et al., 2000).  After injury, Wallerian degeneration in peripheral 
axons is delayed in aged animals (Tanaka 1991), which is believed to be brought 
about by a fading reactivity of non-neuronal cells (Verdu et al., 2000).  Much larger 
myelin remnants accumulate in macrophages compared with young animals 
suggesting slower processing times (Tanaka et al., 1992).  The interaction between 
Schwann cells and regenerative axons is also delayed, combined with a reduced 
concentration of trophic factors secreted by reactive Schwann cells in older subjects 
(Komiyama and Suzuki 1992).  In turn, this may contribute to a reduction in the rate 
of axonal regeneration and the density of regenerating axons.  Terminal and collateral 
sprouting of regenerated fibres is also affected, further restricting the success rate for 
target reinnervation and functional restoration.  Importantly, the capabilities for 
axonal regeneration and reinnervation are still maintained throughout life, but are 
simply delayed and less effective.  
 
The role of Schwann cells following injury has already been discussed (Introduction 
1.4, 1.5) but satellite glial cells also have the ability to respond to various kinds of 
injury or disease, and their close contact to neurons allows small amounts of 
substances released to influence neuronal function (Liutkiene et al., 2007; Griffin and 
Thompson 2008; Hanani 2010), and promote in vitro neurite growth (Lein et al., 2002).  
Like Schwann cells, satellite glial cells are highly motile; (Chamley et al., 1972), 
suggesting that they can change their position and morphology, something that is 
essential for repair following peripheral damage and during phagocytosis. 
 
Nerve injury also prompts ‘synaptic stripping’ (Kreutzberg 1995), a process where 
neurons lose their synaptic inputs and become physically separated from them after 
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axotomy.  While microglia facilitate synaptic stripping in the CNS (Schiefer et al., 
1999), macrophages implement this in SCG (Schreiber et al., 1995).  The involvement 
of satellite glial cells is still unclear but detached presynaptic elements were found 
enveloped by lamellae of satellite glial cell cytoplasm (Matthews and Nelson 1975) 
thus implicating satellite glial cells in this process. 
 
Mechanical insult to the peripheral nerve initiates a cascade of molecular events in the 
distal nerve stump that promotes myelin degeneration followed by dedifferentiation 
and proliferation of the Schwann cells.  In adult animals, when the nerve is damaged, 
myelinating and non-myelinating Schwann cells have the ability to revert back to a 
non-differentiated, proliferative phenotype.  It has recently been suggested that this 
injury-induced cell plasticity facilitates a transdifferentiation that generates a 
specialised repair cell, also termed a Büngner cell, which can be distinguished from 
the Schwann cells found in the developing nerve.  These repair cells guide regrowth 
of the injured axons and eventually remyelinate them to allow functional recovery of 
the damaged nerve (Arthur-Farraj et al., 2012). 
Schwann cells are also involved in other repair processes such as the breakdown of 
the blood-nerve barrier and the recruitment of macrophages to the site of injury to 
clear myelin debris.  Further studies are necessary to completely understand the 
molecular mechanisms that control the regenerative properties of the Schwann cell.  
What is clear is that adult Schwann cell plasticity is regulated by a complex array of 
signalling pathways and transcription factors in response to injury.  Among these are 
JNKs, as well as ERKs and p38 MAPK, which are involved in mediating the injury 
signal that initiates the Schwann cell de-differentiation process.  These MAPKs act as 
negative regulators of Schwann cell differentiation and myelination, thus facilitating 
the transition toward the immature phenotype (Myers et al., 2003; Harrisingh et al., 
2004; Ogata et al., 2004; Zrouri et al., 2004; Parkinson et al., 2008; Syed et al., 2010; 
Yang et al., 2012).  Despite links with JNK (Parkinson et al., 2004; Monje et al., 2010), 
more focus has been placed on the ERK/p38 MAPK signalling pathways (Harrisingh 
et al., 2004; Guertin et al., 2005; Napoli et al., 2012; Yang et al., 2012). 
 
 
 
 
 
		
	 	
  Results  
	
	 	
85 
 Glial responses further downstream 3.2.1.3
 
While c-Jun has been shown to play a significant role in the regeneration of neurons 
(Raivich et al., 2004; Ruff et al., 2012), it has also been assessed in Schwann cells 
during the functional repair of peripheral nerves after injury (Jessen and Mirsky 2008; 
Arthur-Farraj et al., 2012).  A downstream target of JNK, c-Jun is up-regulated after 
injury in both myelinating and non-myelinating Schwann cells that are removed from 
axonal contact of sensory neurons (Parkinson et al., 2008).  Satellite glial cells have 
also been implicated in pathological changes following injury to SCG and 
observations indicate induced expression of c-Jun, Jun B and Jun D (Koistinaho et al., 
1993).  
 
Conditional deletion of c-Jun in Schwann cells does not appear to affect development 
or myelination of peripheral nerves.  However, in adult nerves following injury, 
Schwann cells lacking c-Jun failed to down-regulate myelin proteins and take on the 
repair cell state.  This distinct lack of repair in c-Jun-null nerves suggested that the 
formation of Büngner cells from the dedifferentiation of Schwann cells is dependent 
on c-Jun (Arthur-Farraj et al., 2012).  Studies have since shown that sciatic nerve injury 
induced c-Jun activation is JNK-independent in adult Schwann cells (Blom et al., 
2014), but this is yet to be explored in sympathetic glia.   
 
 Growth factor signalling	3.2.1.4
 
Ultimately the function of Schwann cells is specifically to produce both the 
environment and neurotrophic support necessary for effective axonal regeneration, 
and repair of the adult nerve.  The actions of NGF and other neurotrophins on 
sympathetic neurons are well elucidated but the role of satellite glial cells and non-
myelinating Schwann cells in neurotrophic signalling and, conversely, the trophic 
effect on glia, has received less attention.   
 
Previous studies reveal that Schwann cells are NGF-responsive (Taniuchi et al., 1988) 
but they also have the ability to synthesise and secrete a wide range of growth factors, 
NGF being one of them (Assouline et al., 1987; Heumann et al., 1987; Bampton and 
Taylor 2005).  NGF levels are increased in Schwann cells post-axotomy (Assouline et 
al., 1987; Bandtlow et al., 1987; Matsuoka et al., 1991; Weidner et al., 1999) and it has 
been suggested that injury acts as a trigger to induce neurotrophin production 
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(Taniuchi et al., 1988; Matsuoka et al., 1991).  Immunohistochemistry and in situ 
hybridization by Wetmore and Olson (1995) revealed that satellite glial cells in adult 
rat SCG contain BDNF mRNA and TrkB transcripts but not TrkA and TrkC 
suggesting that NGF production and responsiveness is limited to Schwann cells in 
that environment. 
 
3.2.2 Aims 
 
In current research, much consideration has been given to the importance of JNK in 
neurodegeneration and age-related diseases.  However, there is still much to be learnt 
about the physiological responses of glia in aged sympathetic ganglia.   
In the first section of this study, experiments also demonstrated an impact on the 
growth of glial extensions, as well as glial proliferation, in response to JNK inhibition.  
Therefore, the hypothesis is that JNK inhibition has an important role to play in the 
differentiation of young adult and aged SCG glia too.   
There may also be an indirect effect of glia on neuronal responses in young adult and 
aged SCG cultures.  In this section, the effect of JNK of young adult and aged glial 
phenotype will be assessed, including their relationship with neurons. 
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3.2.3 Results 
 
 Effect of JNK inhibition on glial proliferation and process outgrowth 3.2.3.1
 
Unlike neurons, glial cells possess the ability to divide post-development, and often 
proliferate when explanted in culture.  As cultures in the first section were treated 
with AraC (see Methods, 2.2.4) to suppress any glial proliferation, it was possible that 
the phenotypes of the glia were altered and the effects of JNK inhibition were 
masked.  In order to clarify this, the survival and growth of glia in the presence of 
JNK inhibitors was assessed in AraC-free medium. 
Without AraC in control SCG cultures of young adult and aged dissociated neuronal 
and non-neuronal cells, glia proliferated extensively, and grew long processes by day 
2 (see Methods).  On Day 1 of culture, glial cells are yet to form glial extensions so 
photographs were taken to observe the effect of different JNK inhibitors on Day 3 (Fig 
3.9).    
AEG3482 and JNK Inhibitor II completely restricted the growth of glial extensions 
and arrested glial proliferation.  JNK Inhibitor III was less effective at restricting glial 
extension than JNK inhibitor II.  JNK inhibitor VIII (inhibits JNK 1+2 more 
effectively that JNK 3) also showed some restriction of growth.  However, JNK 
inhibitor IX, ATP competitive inhibitor of JNK2 and JNK3, completely abolished the 
formation of glial extensions.  By Day 3, the cultures appeared to possess a lot of 
debris, with glial processes breaking off and the glial cell body shrivelling up.  It is 
not possible to determine whether glial cells are alive by morphological criteria, 
therefore, to elucidate whether JNK inhibition purely restricts growth or kills glial 
cells, a Live/Dead assay was performed on Day 2 of culture.  Results clearly showed 
that there was no effect of JNK inhibitor IX on glial survival (Figure 3.9, G) and what 
was being observed was a clear restriction in the formation of glial processes.  
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Figure 3.9: Representative phase contrast images of NGF-treated glial cells in 
aged SCG cultures after the treatment of various JNK inhibitors for 72 hrs. 
 
All cultures were NGF (0.4nM) treated and the JNK inhibitors were administered at 10#M, 
AEG3482 (40#M).  (A) NGF control, (B) JNK inhibitor III, (C) AEG3482, (D) JNK inhibitor II, 
(E) JNK inhibitor VIII and (F) JNK inhibitor IX. Scale bar = 100#M (G) Live-dead assay 
demonstrated that the survival of JNK inhibitor IX-treated glia is not significantly different 
from that of NGF control, despite the dramatic effect on growth and the unhealthy appearance 
of the cells (p=0.91). Data is representative of three experiments. 
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 Glial impact on neurons 3.2.3.2
 
Glial cells possess the ability to promote trophic effects in neuronal cells through a 
local supply of NGF (Assouline et al., 1987) , although neurite outgrowth is not solely 
dependent on the NGF secreted by glia.  It is difficult in these experiments to evaluate 
the difference between young adult and aged cultured neurons because each culture 
requires different preparation.  However, similar trends were observed in the effect of 
various JNK inhibitors on the NGF-dependent growth of neurites and glial processes 
(Table 3.1) in adult and aged SCG cultures, with the addition or absence of AraC.  
While JNK inhibition may not be signalling through the same pathway in neurons 
and glia, similar effects on growth are observed in both cell populations. 
 
 
Table 3.1: Summary of the effects of JNK-inhibiting compounds on the 
growth of NGF-treated SCG glia and neurons from young adult and aged 
mice in the absence of AraC. 
 
Inhibitor Mode of action Growth of glial processes  
Growth of 
neurites 
JNKi II ATP competitive inhibition of JNK 
Substantial 
restriction 
Substantial 
restriction 
JNKi III 
Cell permeable 
peptide disrupts 
cJun/JNK 
Some restriction  Some restriction 
JNKi VIII ATP competitive inhibition of JNK 1+2  Some restriction Some restriction 
JNKi IX ATP competitive inhibition of JNK 2+3 
Completely 
restricted  
Completely 
restricted 
AEG3482 
Bind HSP90, which 
indirectly increases 
HSP70, which inhibits 
JNK 
Substantial 
restriction 
Substantial 
restriction 
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3.2.4 Discussion 
 
The growth and proliferation of glia was restricted by JNK inhibition in cell cultures 
of aged mouse SCG.  Under these conditions, AEG3482, pan-JNK inhibitor II and 
JNK inhibitor IX had the strongest inhibitory effect whereby glial proliferation was 
arrested and the growth of glial extensions was severely restrained.   
 
There was some restriction of JNK inhibitor III (Fig 3.9) on glial processes in culture, 
while the impact of JNK inhibitor VIII was slightly more pronounced.  Interestingly, 
within cultures treated with JNK inhibitor IX, glia appeared shrunken, with 
complete elimination in the extension of glial processes.  In order to determine 
whether this appearance signified cell death, or simply a considerable impact on 
growth without cell death, a Live/Dead assay was performed.  Results confirmed 
that, while there was a radical change to the glial phenotype, the cells retained both 
intact membranes and intracellular esterase activity, suggesting that JNK inhibitor IX 
did not affect glial survival.  As JNK inhibitor IX (ATP competitive inhibitor of JNK2 
and JNK3) is much more effective at restricting glial process and proliferation than 
JNK Inhibitor VIII (inhibits JNK 1+2 more effectively that JNK 3), these observations 
suggest that, as with neurons, JNK3 is likely to be particularly important for the 
growth of glial cells.  
 
These results may have therapeutic implications in the use of JNK inhibitors for 
neurodegeneration and neuronal injuries acquired at any stage of life.  It has been 
previously discussed that the JNK signalling pathway could be a potential therapeutic 
target in peripheral nerve injury and repair due to activation through a wide range of 
cellular stresses, as well as inflammatory mediators, which are also active in nerve 
injury.  While emphasis has generally been consigned to the targeting of JNK 
signalling in neurons, there may also be benefits to inhibiting JNK in glia under 
harmful conditions.  In particular, gliosis in the brain is an increasing problem, 
whereby a proliferation of glia following brain injury can be damaging to the 
surrounding neurons (Robel et al., 2011).  Similarly, glial scar formation due to 
reactive astrogliosis following spinal cord injury forms an impenetrable barrier for 
regenerating axons (Yuan and He 2013).  It may be that treatment with JNK inhibitors 
are useful for an acute period of time to inhibit the formation of additional glia, 
without affecting the survival of existing glia and nearby neurons.   
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The time it takes to facilitate nerve repair is a significant challenge when it comes to 
ageing.  The complex signal transduction pathways initiated in cells following 
peripheral nerve injury, and the interactions between neurons and glia are delayed in 
older subjects.  Therefore, further studies would be required using extended time 
periods to make sure there is no long-term detriment to regeneration and outgrowth. 
 
Further downstream, it has been found that sciatic nerve injury-induced c-Jun up-
regulation, which is necessary for the formation of Bunger cells, is JNK-independent 
(Blom et al., 2014).  Induced expression of c-Jun, Jun B and Jun D has also been 
observed in satellite glial cells following injury to SCG (Koistinaho et al., 1993), 
however it is yet to be determined whether this is JNK-independent.  Therefore, it 
would be relevant to assess c-Jun and other downstream targets affected by JNK 
inhibition, and the restrictive activity controlling glial process outgrowth and 
proliferation.  Some inhibition of glial process outgrowth was also observed in 
cultures treated with pan-JNK Inhibitor III, which is a cell permeable peptide that 
specifically disrupts the JNK/c-Jun interaction.  Therefore, JNK/c-Jun is likely to be 
involved to some extent in the process of young adult and aged SCG glial 
proliferation but further studies are required to confirm this. 
 
While pan-JNK inhibitor II works by ATP competitive inhibition of JNK, it is not 
known through which mechanism AEG3482 inhibits growth.  Interestingly, work by 
Hou et al. (1998) found an up-regulation of HSP70 in satellite glial cells, as well as 
neurons, in rat SCG after carotid nerve axotomy, which suggests a role for HSP70 in 
glia as well.   Results in the previous section show that HSP70 levels are unaffected in 
young adult and aged neurons after the administration of AEG3482, which suggests 
that JNK-inhibition induced restriction of neurite outgrowth is perhaps occurring 
through a different mechanism.  Further studies are required to elucidate whether this 
is also true of glia.   
 
When SCGs are dissociated and cultured, neurons are damaged, so it is likely they are 
in a state of repair.  In the periphery, regeneration of neuronal networks is facilitated 
with the support of Schwann cells, satellite glial cells and macrophages.  However, in 
culture conditions, as those described above, which have a low plating density, glial 
cells are sometimes far from neurons.  In addition, neurons attached to glial cell 
bodies were not scored.  Due to the nature of the methodological process in culturing 
neurons, it is also possible that some glia are removed via differential sedimentation.  
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Therefore neurons received little or no glial support in this culture model.  This is 
further supported by the lack of an effect of AraC (inhibits glial proliferation and 
process outgrowth) on the survival and growth of neurons on Day 2 of culture 
(Materials and Methods, 2.2.4).    
   
Going forwards, it would also be of interest to fully characterise the population and 
composition of specific glia post-injury in adult SCG and during ageing.  As satellite 
glial cells and Schwann cells display different characteristics and possess different 
biological functions, it would be relevant to understand the regulatory processes 
involved.  To help differentiate between different classes of glia, Taveggia et al. (2005), 
proposed treating all Schwann cells as non-myelinating unless they possess threshold 
levels of neuregulin-1 type III (NRG1), a member of the epidermal growth factor 
(EGF) family.  Satellite glial cells, however, do not require neuregulin for normal 
developments in sympathetic ganglia (Jessen and Mirsky 2005) so this provides a 
method of distinguishing between the two glial sub-types. 
 
Having filtered through the literature, the information on the influence of 
sympathetic glia on neuronal behaviour is still sparse and will require much more 
attention to fully decipher their relationship in ageing and following injury or insult. 
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3.3 Is proNGF signalling JNK dependent?
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3.3.1 Introduction 
 
For many years, the unavailability of NGF was thought to be responsible for a 
neurotoxic effect in neurons in ageing (see Introduction).  However, since the turn of 
the century, reports have indicated that proNGF mediates this effect and has an 
essential role in neurodegeneration.  Furthermore, proNGF has also been implicated 
in the neurite outgrowth of subpopulations of NGF-responsive young adult and aged 
neurons and may also be important for neuronal repair after injury (Al-Shawi et al., 
2008). 
 
Throughout life, the amount of proNGF is dynamically regulated and levels have 
been reported to increase in ageing (Nykjaer et al., 2004; Al-Shawi et al., 2008), disease 
(Pedraza et al., 2005; Chen et al., 2008; Stoica et al., 2008; Belrose et al., 2014) and after 
injury (Harrington et al., 2004).  Fahnestock et al. (2001) found proNGF to be the 
predominant form of NGF protein in adult mouse, rat, and human brain tissue, 
whereas very limited levels of mature NGF (mNGF) were detected; lack of mNGF 
may be a result of being rapidly transported after being processed.  The levels of 
proNGF continue to increase in SCG of one-year old mice, which show a higher 
concentration compared with 7-week old adult animals (Jansen et al., 2007).  This 
observation also ties in with reports of a 50-fold increase of proNGF levels in 
sympathetic ganglia of two-year old rats (Bierl and Isaacson 2007). 
 
Interestingly, increased proNGF levels in aged SCGs were not paralleled by a similar 
rise in mRNA concentrations, as determined by RT-PCR, suggesting that post-
transcriptional mechanisms affect neurotrophin production and accumulation in the 
tissue (Hasan et al., 2003; Jansen et al., 2007).  Work by Jansen et al. (2007) suggested 
that it was unlikely for retrograde transport of target-derived proteins to be 
responsible for accumulation of proNGF in SCGs because no increase in pro-
neurotrophin production was evident in aged middle cerebral arteries, following 
analysis of Western blotting or RT-PCR.  However, strong co-localisation was 
observed between proNGF and tyrosine hydroxylase, which defines sympathetic 
neurons using double immunostaining.  Therefore, it was concluded that proNGF 
may originate from ageing SCG neurons themselves. Local production of proNGF 
was also confirmed by in situ hybridisation, where NGF mRNA transcripts were 
found in SCG neurons from 60-week old mice.   
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Developmental regulation of proNGF levels forms the basis for the differing 
responses of proNGF signalling.  Unlike young adult neurons, NGF-responsive BFCN 
and SCG neurons from aged rodents are vulnerable to proNGF-mediated cell death 
(Jansen et al., 2007; Al-Shawi et al., 2008).  As well as an exposure to increased levels 
of proNGF in vivo (Bierl and Isaacson 2007; Al-Shawi et al., 2008), aged neurons 
express higher levels of sortilin (Al-Shawi et al., 2008), which acts to enhance binding 
of proNGF to p75NTR (Nykjaer et al., 2004).  Therefore execution of this neurotoxic 
signalling function may be determined by both the availability of proneurotrophins, 
and cell surface receptors (Fahnestock et al., 2004; Al-Shawi et al., 2008; Masoudi et 
al., 2009).  This has been further supported in PC12 cells where increased 
vulnerability to proNGF-mediated cell death is observed under conditions in which 
the ratio of p75NTR relative to TrKA is increased (Masoudi et al., 2009).   
The dependence on neurotrophin availability has also been observed in 
subpopulations of SCG neurons, which exhibit different degrees of vulnerability 
during ageing.  Rat SCG neurons projecting to cerebral blood vessels (CV) are 
significantly reduced with a cell loss of 15% by mid-age with further losses by old 
age, while iris-projecting neurons only suffer significant losses by old age (Al-Shawi 
et al., 2008).  Interestingly, Al-Shawi et al. (2008) found twofold lower levels of 
proNGF in the iris compared with the CV at mid-age.  Therefore, the distribution of 
proNGF in the nervous system has become a vital part of research, especially as 
earlier antibody studies failed to distinguish between neurotrophins and their 
precursors.  
Differential regulation of proNGF signalling may be achieved through the existence 
of several proNGF forms (Introduction 1.3).  Two different transcript products 
(Ullrich 1983, Edwards 1986), accompanied by several potential targeted sites for 
convertases and glycosidase can create different proNGF forms, and can vary from 
one tissue to another.  Pedraza et al. (2005) discovered four different immunoreactive 
bands corresponding to proNGF in human brain tissue affected by AD alone (26, 32, 
37 and 53kDa).  Densitometry analysis further presented differences in the increase of 
different proforms, at different stages of AD, in different sections of brain.  In 
entorhinal cortex, the 53kDa band increased and, in frontal cortex, the same proform 
increased along with 37 and 32kDa forms of proNGF.  Three of these proforms 
induced apoptotic cell death (53, 32 and 26kDa) when pooled in p75NTR:SCG primary 
neurons cultures. 
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For proNGF-mediated growth signalling, some suggest an initial requirement for 
proNGF cleavage to mNGF, which subsequently binds and signals via TrkA, as 
shown in PC12 cells (Boutilier et al., 2008) and in the presence of glia (Kalous et al., 
2012).  In adult sensory neurons (DRG), Kalous et al. (2012) proposed that the 
proNGF-mediated neurotrophic response is indirectly mediated by NGF and TrkA, 
through sortilin- and p75NTR-dependent cleavage of proNGF, to mNGF, in peri-
somatic glia.  The potential ability of a targeted local supply of mNGF supplied by 
glial cells may provide an important regulatory action to promote trophic outcomes, 
as opposed to cell death, under conditions where regeneration or sprouting is 
required.  Interestingly, immunocytochemistry in sections of young adult and aged 
SCG from old mice suggest that sortilin is not present in glia from sympathetic 
neurons (Al-Shawi et al., 2008).  Therefore, the outcome of proNGF signalling in SCG 
may be partly regulated by cleavage through pro-protein convertases e.g. furin, 
proteases e.g. MMP-7, and not glia.  In any case, proNGF has still been found to have 
neurotrophic effects without any cleavage at all.  Howard et al. (2013) demonstrated 
that in the absence of surrounding glia, using compartmentalised chambers, cleavage-
resistant proNGF can still promote neuritogenesis of developing cultured sympathetic 
neurons.   
 
In experimental studies, different forms of proNGF have also been developed over 
time, from wild type to cleavage-resistant mutations, of which binding characteristics 
have been evaluated (Clewes et al., 2008; Masoudi et al., 2009).  This, coupled with the 
methodological differences employed in different studies, may contribute to the 
differing cellular responses of proNGF (Introduction 1.3). 
 
For example, Fahnestock et al. (2004) used a cleavage-resistant proNGF (34kDa), 
produced in Sf9 insect cells, which disrupts the tetrabasic cleavage site (R-1G).  A high 
density of SCG neurons were cultured (20,000 neurons per 35 mm dish), and an 
increase in the proportion of growing neurons, with enhanced survival, was observed 
through binding TrkA, when treated with proNGF.  Similar results were obtained by 
Howard et al. (2013), using the same cleavage-resistant proNGF.  In contrast, the 
cleavage-resistant proNGF administered by (Lee et al., 2001), which has different 
amino acid substitutions  (−2, −1, 118 and 119.  RR to AA), promoted apoptosis and 
had negligible interactions with TrkA, thus preventing neurite growth from SCG 
neurons (Park et al., 2001).  However, Masoudi et al. (2009) discovered proNGF 
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enhanced the survival of SCG neurons, rather than promoting apoptosis, and 
increased the number of neurons with neurite outgrowth, with the same cleavage-
resistant proNGF as Lee et al. (2001).  Masoudi et al. (2009) obtained similar results 
when using an additional cleavage-resistant proNGF with multiple amino acid 
substitutions (−73 and −72, RR to AA; −43 and −42, KKRR to KAAR; and −2 and −1, 
KR to AA) (Pagadala et al., 2006) and another with two different substitutions (−1 and 
+1 RS to AA).   Importantly, SCG neurons were also plated at an exceptionally high 
density in these studies.  
 
Clewes et al. (2008) used wild-type proNGF, and a human recombinant furin-resistant 
proNGF (M-proNGF) R121A, S122A (both 24.8kDa), produced from E. coli and 
refolded, devoid of extraneous purification tags.  M-proNGF was bound to HEKTrkA 
at the same affinity as wild-type proNGF.  Both M-proNGF and mNGF-induced 
phosphorylation of TrkA and ERK1/2 signalling.  In the Howard et al. (2013) study, 
two different forms of cleavage-resistant proNGF and native proNGF elicited neurite 
growth of the same magnitude and neuronal specificity.  For studies in aged SCG 
neurons, Al-Shawi et al. (2008) administered a wild-type proNGF in culture, and 
observed neurite outgrowth in cultured young adult and aged SCG neuron from aged 
rats.  Interestingly, no significant cell-death of young adult SCG neurons was 
observed in this study but there was neurotoxicity in aged SCG; so different 
methodology doesn’t necessarily explain age dependent cell-death. 
 
Comprehensive studies, in vitro, have shown that cleavage-resistant proNGF can 
promote neurite outgrowth in populations of NGF-responsive neurons but can also 
mediate a neurotoxic effect in aged neurons.  Overall, it may be that in ageing, 
proNGF-mediated regulation of survival and growth in vivo is determined by the 
availability of intracellular and extracellular cleavage proteins which cleave proNGF 
to mNGF, but also the local supply of proNGF, combined with the expression of 
receptor complements e.g. sortilin and p75NTR or TrkA.  Regulation of downstream 
effectors may also be important. 
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 Role of NRAGE in aged neurons 3.3.1.1
 
NRAGE, an 86kDa cytoplasmic protein, was first identified by Salehi et al. (2000), to 
directly interact with p75NTR and facilitate apoptosis of NGF-responsive neurons in 
PC12 cells (Salehi et al., 2002).  NRAGE contains a ∼200-amino acid MAGE homology 
domain (MHD) (Barker and Salehi 2002), which binds to the juxtamembrane domain 
of p75NTR in vitro and in vivo.  It acts by blocking the physical association of p75NTR 
with TrkA and appears to compete with TrkA for the same site on p75NTR.  NRAGE 
over-expression facilitates cell cycle arrest and p75NTR-dependent apoptosis within 
PC12 cells.  In contrast, TrkA overexpression abolishes NRAGE-mediated death, 
suggesting p75NTR forms independent complexes either with NRAGE or with TrkA.  
NRAGE expression was also necessary for p75NTR-dependent apoptosis of MAH cells 
and this was blocked by TrkA expression (Salehi et al., 2000). 
p75NTR/NRAGE dependent apoptosis involves the JNK pathway, and subsequent 
cytosolic accumulation of cytochrome c, activation of Caspases-3, 9 and 7, and 
caspase-dependent cell death in NGF-responsive neurons (Salehi et al., 2002; Bhakar 
et al., 2003; Salehi et al., 2006).  Blocking downstream targets; JNK and c-Jun, by 
overexpression of the JNK-binding domain of JIP1 or dominant-negative c-Jun, arrests 
NRAGE-mediated caspase activation and NRAGE-induced apoptosis in PC12 cells 
(Salehi et al., 2002).  In vivo studies on NRAGE KO mice, and studies on primary 
sympathetic neurons derived from these mice, also support a role for NRAGE in 
p75NTR -mediated cell death (Bertrand et al., 2008). 
NRAGE is also involved in neuritogenesis, although the exact role is yet to be 
confirmed due to a certain degree of variability.  In PC12 cells, which differentiate in 
response to NGF, NRAGE was found to act as a negative regulator of neurite 
outgrowth by activation of the TrkA-ERK signalling pathway (Feng et al., 2010).  
However, growth-promoting effects have been reported by Reddy et al. (2010), while 
in NRAGE KO mice, neuronal growth was found to be normal (Bertrand et al., 2008).  
Again, these patterns have only been observed in PC12 cells and development, so it is 
relevant to observe the impact in aged neurons. 
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3.3.2 Aims 
 
Apoptosis in NGF-dependent neurons is facilitated by p75NTR and its cytosolic 
interactor, NRAGE, but attenuated by JNK inhibition.  Pan-neurotrophin receptor, 
p75NTR, is also required to elicit proNGF-mediated neurotoxic effects in ageing, 
therefore it is hypothesised that NRAGE and JNK are also involved in this signalling 
response.   
 
Similarly, proNGF has been shown to promote neurotrophic effects in aged 
sympathetic cultures although the molecular pathway through which it acts is still 
unclear. 
 
This section aims to observe whether the proNGF-mediated cell death and growth 
promoting activities are JNK-dependent, by administering JNK inhibitors in proNGF-
treated SCG neuron cultures from aged mice.  NRAGE siRNA knockdown in the 
same cultures will also seek to establish whether p75NTR/NRAGE is involved in the 
proNGF- signalling response in aged neurons.   
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3.3.3 Results 
 
SCG neurons from aged mice were cultured as normal then subjected to cleavage-
resistant proNGF (Alomone Labs) treatment.  Young adult neurons were not assessed 
because proNGF was not neurotoxic in whole populations of cultured SCG neurons 
from this age-group, as determined by Al-Shawi et al. (2008). 
 
Following administration of 0.6nM proNGF, there was no significant effect in the 
survival of aged SCG neurons on Day 1 (Fig 3.10).  In some systems, NRAGE activity 
has been identified to take 2-3 days activation (Salehi et al., 2000), so to observe 
whether there was a delayed response, cells were followed for three days.  On Day 3, 
the survival of proNGF-treated neurons still remained insignificantly different from 
control-treated cultures.   
 
 
 
  
 
Figure 3.10: Survival of aged sympathetic neurons in pro-NGF treated 
cultures 
 
(Day 1+3) proNGF (Alamone) treatment (0.6nM) did not have a significant effect on neuronal 
survival, relative to control (n=300). 
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To maximise any response, a higher concentration of proNGF (1.2mM) was 
administered, and survival and growth was monitored.  Cells were followed for 3 
days as before. 
 
The effect on the survival of proNGF-treated aged SCG neurons was insignificant on 
Day 1 and Day 3.  However, the proportion of growing neurons in proNGF-treated 
wells relative to control is increased by 4-fold in aged SCG cultures containing 1.2nM 
proNGF on Day 1 (Fig 3.11); on Day 3, this ratio fell to 3-fold because of a delayed 
growth response in control cultures. 
  
 
 
 
 
Figure 3.11: Survival and neurite outgrowth of aged sympathetic neurons in 
proNGF-treated cultures  
 
(Day 1 and Day 3) proNGF (1.2 nM) treatment had no significant effect on survival but 
significantly increased the proportion of aged SCG neurons with neurite outgrowth, relative to 
control  (p<0.0001; n=300). 
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 proNGF-mediated toxicity in the absence of insulin 3.3.3.1
 
One difference between these experiments and those conducted by Al-Shawi et al. 
(2008), whereby a neurotoxic effect on aged SCG neurons was observed in proNGF-
treated cultures, was the presence of insulin in serum-free culture media.   
 
Previous work on the brain has demonstrated neuroprotective roles for insulin, a 
polypeptide hormone that serves as a growth factor amongst a host of other 
functions, such as regulating enzymatic pathways involved in energy storage, and 
synthesis of structural proteins.  A role for insulin in central neurons following 
cerebral ischemia is to activate protein kinase B (PKB/Akt), which subsequently 
mediates anti-apoptotic actions of growth factors in cells (Downward 1998).  In rat 
hippocampal neurons, activation of Akt1, via stress-induced ischemia, inhibited 
phosphorylation of JNK1/2, c-Jun, Bcl-2 and attenuated caspase-3 activation thus 
halting cell death (Hui et al., 2005).  
 
Binding of insulin to the insulin receptor causes receptor auto-phosphorylation and 
exposure of phosphorylated residues that function as docking sites for insulin 
receptor substrate (IRS) and adaptor proteins (Shc, Gab1, APS).  Phosphorylation of 
IRS-1 promotes the activation of the p85 regulatory subunit of PI3K, which 
subsequently modulates PKB/Akt (Gallagher et al., 2010).  Previous studies in rat 
sympathetic neurons during early development demonstrated that overexpression of 
PI3K or its downstream effector Akt blocked cell death after NGF withdrawal, in spite 
of the fact that the c-Jun pathway was activated (Philpott et al., 1997).   
 
To eliminate the effects of insulin on survival and growth, as previously (Al-Shawi et 
al., 2008), further experiments were carried out in insulin-free medium (neurobasal-A 
medium supplemented with insulin-free B27).  Cells were followed for three days to 
observe whether there was a delayed or prolonged effect of proNGF. 
 
In insulin-free medium, proNGF significantly reduced the survival of SCG neurons 
from aged mice on Day 1 and Day 3  (Fig 3.12).  The percentage difference in survival 
of proNGF-treated cells, relative to control, was approximately 32% on Day 1 and 17% 
on Day 3, suggesting that proNGF-induced cell death is set into motion at an early 
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stage or that there is a larger population of dead neurons in control-treated wells, on 
Day 3, thus lowering the control population of surviving neurons. 
 
In the same cultures, neurite outgrowth was substantially improved in the presence of 
proNGF.  On Day 1, the proportion of growing neurons in proNGF-treated cultures 
was 4-fold higher than the control, and this proportion of growing neurons, relative to 
control, was maintained across the three days. 
 
 
 
 
Figure 3.12: Survival and neurite outgrowth of proNGF-treated aged 
sympathetic neurons (without insulin) 
 
(Day 1 and Day 3) proNGF treatment significantly reduced neuronal survival (p<0.0001) and 
increased the proportion of aged sympathetic neurons with neurite outgrowth, relative to 
control (p<0.0001; n=900).   
 
 
Earlier in this study, experiments on aged mice revealed that AEG3482 had no effect 
on the survival of SCG neurons, possibly because older neurons are not dependent on 
NGF for survival.  Therefore, to identify whether JNK is involved in proNGF-
mediated killing of aged neurons, AEG3482 was administered to proNGF-treated 
cultures. 
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In cultured aged SCG neurons, proNGF-mediated cell death (approx. 30%) was 
inhibited in the presence of AEG3482 (Fig. 3.13).  In the same cultures, proNGF-
mediated growth of SCG neurons was restricted by AEG3482.  The proportion of 
growing neurons in culture compared to proNGF-treated cultures alone was reduced 
by 85% on Day 1.  Altogether, these results imply that JNK is involved in proNGF-
mediated signalling.  On Day 3, the ratio of surviving neurons compared to proNGF 
control was increased in AEG3482-treated cultures, although neurite outgrowth was 
completely eliminated.   
 
 
 
 
 
Figure 3.13: AEG3482 rescues aged SCG neurons from the neurotoxic effect of 
proNGF and reduces proNGF-induced neurite outgrowth 
 
(Day 1)  AEG3482 rescued neurons from proNGF-mediated cell-death (p<0.0001), and 
significantly decreased the proportion of proNGF-induced aged SCG neurons with neurite 
outgrowth (p<0.0001).  (Day 3)  AEG3482 rescued neurons from proNGF-mediated cell-death 
(p<0.0001), and eliminated any proNGF-induced neurite outgrowth of aged SCG neurons 
(p<0.0001) (n= 900).   
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 NRAGE 3.3.3.2
 
AEG3482 rescues neonatal SCG neurons from NRAGE-mediated cell death through 
JNK, so further experiments were required to determine if the deleterious effects of 
proNGF on aged neurons are also mediated by NRAGE. 
 
In these experiments, NRAGE knockdown was achieved by siRNA, which was 
administered in culture (Materials & Methods 2.8).  RNA oligos were coupled to 
Penetratin-1 prior to delivery.  To confirm the efficacy of NRAGE knockdown, siRNA 
was administered in neonatal SCG cultures in the absence of NGF.  Newly isolated 
sympathetic neurons, derived from rodents, die within 24 hours of plating in culture 
unless provided with NGF (Chun and Patterson 1977).  Therefore, in the neonatal 
experiment, NGF was included within all media post-SCG excision.  NGF-free 
medium was substituted in culture wells containing control siRNA and NRAGE 
siRNA.  
Findings show that the survival of neonatal neurons was significantly better in the 
presence of NRAGE siRNA, following NGF withdrawal.  As expected, siRNA 
knockdown of NRAGE prevented the death of neonatal SCG neurons by 13%, all 
relative to NGF control.  In contrast, experiments on SCG neurons cultured from old 
mice demonstrated that NRAGE siRNA had no significant effect on neuronal survival 
on Day 1 (Fig. 3.14). 
Data also revealed that NRAGE siRNA had no effect on the neurite outgrowth of 
aged SCG neurons on Day 1 and that Penetratin-1 had no significant effect on the 
survival and growth of NGF-treated SCG neuron cultures (results not shown). 
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Figure 3.14: Effect of NRAGE siRNA on survival of neo-natal and aged SCG 
neurons 
 
In neonates, NRAGE siRNA (80nM) significantly increased the survival of SCG neurons after 
NGF withdrawal (p<0.0001;n=300).  Survival in the presence of NGF compared to NRAGE 
siRNA was not significantly different.  In aged mice, NRAGE siRNA had no significant effect 
on the survival of NGF-treated SCG neurons (p=0.50; n=900) 
 
 
NRAGE siRNA was subsequently administered in proNGF-treated SCG cultures of 
old mice.  NRAGE siRNA knockdown significantly improved the survival of 
proNGF-treated aged SCG neurons, whereas neuritogenesis was not affected by 
NRAGE siRNA.  When NRAGE siRNA and JNK inhibitor IX were added together, 
there was no significant change in aged SCG neuronal survival compared to those 
treated with JNK inhibitor IX alone.  However, the effect of JNK inhibitor IX 
superseded the effect of NRAGE knockdown on neurite outgrowth, and proNGF-
mediated growth signalling was completely abolished in aged SCG neurons (Fig. 
3.15).  Similar results were observed using JNK Inhibitor VIII (Fig 3.16) although, as 
observed throughout these studies, there was a less pronounced effect on neurite 
growth with this inhibitor compared to JNK Inhibitor IX. 
 
Overall these results suggest that NRAGE is only involved in survival signalling, 
under these conditions, and is not implicated in the proNGF-mediated and JNK-
dependent neurite outgrowth of aged SCG neurons. 
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.  A 
 
B 
 
 
Figure 3.15: Effect of JNK inhibitor IX and NRAGE siRNA on proNGF-
induced cell death and neurite outgrowth of aged SCG neurons 
 
On Day 1, (A) JNK Inhibitor IX and NRAGE siRNA significantly reduced the proNGF-
mediated cell death of aged SCG neurons (p<0.0001).  (B) NRAGE siRNA had no effect on 
neurite outgrowth of proNGF-treated aged neurons (p<0.0001).  JNK Inhibitor IX significantly 
abolished all neurite out growth of proNGF-treated neurons, also in the presence of NRAGE 
siRNA (p<0.0001)(n =900) 
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B 
 
 
 
 
 
Figure 3.16: Effect of JNK inhibitor VIII and NRAGE siRNA on proNGF-
induced cell death and neurite outgrowth of aged SCG neurons 
 
On Day 1, (A) JNK Inhibitor VIII and NRAGE siRNA significantly enhanced the survival of  
aged SCG neurons, relative to control, in proNGF-treated cultures, (p<0.0001).  (B) NRAGE 
siRNA had no effect on the neurite outgrowth of proNGF-treated aged SCG neurons 
(p<0.0001).  However, JNK Inhibitor VIII significantly reduced the proportion of aged SCG 
neurons with neurite outgrowth in proNGF-treated culture, also in the presence of NRAGE 
siRNA (p<0.0001)(n =900). 
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To assess proNGF receptor levels, the expression or TrkA, Sortilin and NRAGE were 
determined by western blot analysis on SCGs from young adult and aged mice (Fig 
3.16).  No significant differences were observed in all three protein levels between 
young adult and old mice, when normalised against actin expression.  
 
     F      
                             NRAGE                            Sortilin                                 TrkA 
 
Figure 3.17: Western blot analysis of SCG lysates of  and young adult mice 
 
Each lane represents a pooled sample of six SCGs taken from three mice (A) NRAGE 90-
95kDa, detected in the brain, p=0.59.  (B) Actin relating to protein concentrations in A (C) 
Sortilin, 100kDa (D) TrkA, 98kDa not detected in the brain, p=0.24.  E) Actin relating to protein 
concentrations in C/D. (F) No significant difference was observed between age-groups when 
normalised against actin expression for each protein. For each age-group, n=6, non-parametric 
t-test (Mann-Whitney). SCG samples are represented by Om –  males, Of -  females, Ym – 
Young males, Yf - Young females.  Con – brain tissue. 
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3.3.4 Discussion 		
The foremost finding in this section is that JNK signalling is involved in both the 
proNGF-mediated cell death and neuritogenesis of cultured SCG neurons derived 
from old mice.  JNK inhibition in aged SCG neuron cultures, through AEG3482, JNK 
Inhibitor VIII and IX, significantly rescued neurons from proNGF-mediated cell 
death as well as halting the growth of surviving neurons. 
 
The p75NTR adaptor protein, NRAGE, was also found to be involved in proNGF-
mediated cell death; siRNA knockdown of NRAGE increased the survival of proNGF-
treated aged neurons in culture.  This is in contrast to NGF control-treated cultures, 
where knockdown of NRAGE does not affect survival, and is consistent with earlier 
studies that aged neurons are not dependent on NGF for survival.  While there have 
been reports of a role for NRAGE in neurite outgrowth, siRNA knockdown did not 
affect the neuritogenesis of cultured aged SCG neurons.  Therefore, it is concluded 
that NRAGE is predominantly an important mediator of cell death in both neonatal 
and ageing sympathetic neurons. 
 
Again, it was found that JNK inhibitor IX completely eliminates any neurite 
outgrowth, this time in the presence of proNGF in aged SCG neuron cultures, while 
JNK inhibitor VIII had less restriction.  Similar to results in the first section, this 
indicates an involvement of JNK3 in promoting neurite outgrowth of surviving 
proNGF-treated aged sympathetic neurons.   
 
JNK activation is associated with both regeneration and neuronal cell death, two 
contrasting pathways, which partly explains why neurons do not undergo extensive 
proNGF-mediated apoptosis in vivo.  As discussed earlier (Results, 3.3.1), culture 
conditions may determine the level of proNGF-mediated neurotoxicity in cell culture 
systems.  In the absence of insulin in the cell culture medium, it was found that 
proNGF was neurotoxic, whereas there was no significant effect of proNGF in 
cultures containing insulin, suggesting that insulin was having a neuroprotective 
effect on the survival of aged sympathetic neurons. 
 
Similar to observations in aged rodent SCG neuronal culture studies conducted by  
(Al-Shawi et al., 2008), only a proportion of neurons were killed by proNGF.  SCG are 
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composed of sub-populations of neurons, which project to different targets e.g. 
cerebral blood vessel (CV)-projecting and iris-projecting.  Al-Shawi et al., (2008) found 
that in the CV of young adult rodents, proNGF levels were much higher than in the 
iris, but this was regulated in ageing where similar levels of proNGF were observed 
in both targets.  Levels of proNGF studied by Bierl and Isaacson (2007) in SCG and 
peripheral targets from young adult rodents also show a degree of variability.  This 
may contribute to the differing vulnerability in sub-populations of NGF-responsive 
neurons in ageing.  Additionally, sub-types may contribute to the antagonistic effects 
on survival and growth observed in culture experiments through their complement of 
cell surface receptors.  Immunohistochemistry studies on fixed cultures, soon after the 
addition of various JNK inhibitors, would help to identify how the complement of cell 
surface receptors is affected in these experiments.   
 
In SCG lysates, western blot data revealed there was no difference in the levels of 
TrkA, sortilin and NRAGE levels in young adult compared with aged mice.  TrkA 
levels were consistent with previous studies in SCG, where TrkA expression remains 
unchanged in mature adulthood, and old age (Cowen et al., 2003).  However, the 
expression of sortilin was different to what has been previously observed.  An 
increase in sortilin levels was previously reported in aged rat SCG lysates in 
comparison with young adult lysates and, in the same study, a stronger staining 
intensity was clearly visualised in immunohistochemical studies in aged mouse SCG 
compared to young adult (Al-Shawi et al., 2008).  While sortilin levels may be variable 
across different species, the up-regulation in sortilin reactivity in ageing may be due 
to a change in the intracellular localisation of sortilin; sortilin is known to be recruited 
to the surface to influence pro-NGF mediated cell death.  Variability has also been 
previously observed in NRAGE expression in the brain; there are higher levels of 
NRAGE in the cortex of aged mouse lysates compared to young adult, however there 
is no significant difference in the hippocampus (R. Al-Shawi; J.P Simons, personal 
communication).  In this study it was found that levels do not change in SCG neurons 
of young adult and aged mice.  The difference could be due to the fact that pooled 
samples were used for SCG samples whereas brain lysates were obtained from 
individual rodents.  In any case, these results suggest that NRAGE expression is 
highly variable in the adult nervous system and may be differentially and 
developmentally regulated. 
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The JNK-mediated apoptotic signal in developing sympathetic neurons, following 
NGF withdrawal, involves phosphorylation of c-Jun (Estus et al., 1994; Ham et al., 
1995; Eilers et al., 1998; Bruckner et al., 2001), or a number of other downstream 
effectors (Tapon et al., 1998; Xu et al., 2003; Kristiansen et al., 2011).  While this study 
confirms that proNGF-mediated cell death in aged sympathetic neurons is JNK- and 
NRAGE- dependent, the downstream nuclear pathway involved in this process is still 
unknown.  Therefore, further studies are required to fully characterise this molecular 
signalling pathway.  Similarly, the specific downstream targets involved in the 
process of proNGF/JNK mediated neurite outgrowth are yet to be determined.  
 
It has been suggested that distinct outcomes of positive and negative influences on 
neuronal behaviour may be down to opposing functions of nuclear and cytosolic JNK 
(Bjorkblom et al., 2008).  The cytosolic pool of activated JNK promotes neurite 
outgrowth, through modulation of cytoskeletal proteins (Coffey et al., 2000; Chang et 
al., 2003; Gdalyahu et al., 2004; Tararuk et al., 2006).  Therefore the action of 
neuritogenesis in proNGF-treated cultures, which is restricted by the introduction of 
JNK inhibitors, could be mediated by JNK in the cytosol but further immunostaining 
or radiolabeling would be required to confirm this. 
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4.1 JNK-dependent neurotrophic signalling 
 
In ageing, neuronal loss is observed in peripheral systems alongside slowing rates of 
regeneration in response to injury.  Levels of neurotrophic factors and receptor 
localisation all play their part but the role of downstream effectors is less clear.  While 
reports have highlighted the involvement of the JNK family in neurotrophic 
signalling during neurodegeneration, and age-related diseases, much is yet to be 
discovered in the PNS.  The work presented in this thesis establishes a role for JNK in 
neurotrophin-responsive young adult and aged sympathetic neurons. 
 
JNK inhibitor studies on cultured NGF-treated SCG neurons revealed that JNK has a 
fundamental role in facilitating the regrowth of aged SCG neurons but does not have 
an impact on survival.  Therefore, while JNK is involved in the removal of neurons 
unable to sustain neurotropic support in early development, this study is consistent 
with the notion that aged SCG neurons are not dependent on NGF for survival (Orike 
et al., 2001b; Al-Shawi et al., 2008).  Similar results were found in cultured young 
adult SCG neurons suggesting that adult age does not have an impact on the neuronal 
response to JNK inhibition during NGF signalling.   
 
In line with previous work, proNGF mediates cell death, as well as neuritogenesis of 
aged SCG neuron cultures.  Here, it was demonstrated that JNK assists with proNGF-
induced growth of adult and aged sympathetic neurons and significantly, JNK 
inhibition rescues neurons from proNGF-mediated cell death.  Hence, it appears the 
importance of JNK in survival only manifests itself when a sub-population of neurons 
are subjected to a stimulus promoting cell-death. 
 
We know that localised areas of high proNGF and sortilin levels enhance cell death in 
vulnerable populations of basal forebrain neurons of the CNS, and populations of 
sympathetic neurons of the SCG in aged rodents (Bierl and Isaacson 2007; Al-Shawi et 
al., 2008).  Further studies are necessary to determine whether any particular sub-
population of sympathetic neurons is more susceptible to proNGF/JNK-mediated cell 
death.  
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4.1.1 Pan JNK-inhibition 
 
The findings described above are based on pan-JNK inhibitor studies, whereby all 
three JNK isoforms are inhibited.  The common use of non‐specific small‐molecule 
inhibitors of JNKs can add to the challenge of identifying which MAPK, JNK or p38, 
exerts a given function.  However, the pan-JNK inhibitors used in this study have 
been tried and tested in previous experiments and display a high specificity for JNK 
(Kita et al., 1998; Bennett et al., 2001; Holzberg et al., 2003; Lindwall and Kanje 2005).  
Further use of isoform-specific inhibitors (4.1.2), which display even greater 
specificity for JNK (Szczepankiewicz et al., 2006; Angell et al., 2007), were able to 
support results following the use of pan-JNK inhibitors. 
 
JNK inhibitor II works by competitive inhibition of the JNK ATP binding site and 
JNK inhibitor III specifically disrupts the c-Jun/JNK complex formation.  Despite 
possessing alternate modes of inhibition, the same outcome was achieved in the 
presence of NGF-treated SCG cultures (neurite outgrowth restriction and no effect on 
the survival of aged sympathetic neurons).  AEG3482 was also used in these 
experiments to inhibit JNK.  Following the administration in NGF-treated young 
adult and aged SCG cultures, the same overall outcome was induced.  AEG3482 
works to prevent neonatal NRAGE/JNK mediated cell death by binding to HSP90 
and disrupting the association with heat shock protein transcription factor HSF-1.  
Freely available HSF-1 subsequently induces the expression of HSP70, which is 
known to block JNK activation (Salehi et al., 2006).  In this study, the survival of 
cultured aged SCG neurons was not affected by the addition of AEG3482, however an 
effect on a small population of neurons cannot be ruled out.  Western and 
immunohistochemical studies supported this idea, and even though there was no 
significant difference in HSP70 levels of aged neurons cultured with AEG3482, the 
standard error of mean of HSP70 staining intensities, when normalised against 
control, was extremely high.  Therefore, the differing vulnerability of SCG neuron 
subpopulations may also be a consideration here.  The involvement of HSP70 has also 
been identified in the process of neurite outgrowth.  The HSP70 inhibitor, KNK437 
enhances neurite outgrowth in PC12 cells.  As there was no significant up-regulation 
in HSP70 levels in aged neurons, it may be that AEG3482 is restricting growth via a 
different pathway.  Another possibility is that HSP70 levels were elevated but this 
was not visualised.  
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The impact on survival in proNGF cultures proved to be more obvious and JNK 
inhibition through AEG3482 rescued aged SCG neurons subjected to proNGF-
mediated cell death.  Whether this occurred through AEG3428-induced up-regulation 
of heat shock proteins remains to be investigated.  Similarly, it was quite apparent 
that the growth of aged SCG neurons was severely impaired by AEG3482 and further 
work is required to determine the pathway by which AEG3482 influences this 
reduction.  
 
4.1.2 JNK Isoforms  
 
Previous research indicates that JNK isoforms may have specialised roles within the 
cell, something that is illustrated in the kainic-acid (excitotoxic glutamate receptor 
agonist) induced injury model of adult transgenic mice.  In JNK1 KOs, increased 
neuronal degeneration compared to wild-type mice is observed (along with a 
tendency for enhanced seizures), JNK2 KOs are unaffected, and JNK3 KOs attenuated 
seizures and decreased neurodegeneration (Brecht et al., 2005).  This, combined with 
the idea that improved neuroprotection could be achieved through selective 
inhibition of JNK isoforms has powered the search for isoform-specific inhibitors, 
particularly for JNK2 and JNK3 isoforms, which clearly display pro-death properties 
in neurons of the adult brain (Yang et al., 1997; Coffey et al., 2002; Brecht et al., 2005). 
Previous studies implicate JNK3 in the p75-mediated apoptosis of neonatal 
sympathetic neurons after NGF withdrawal (Bruckner et al., 2001; Kenchappa et al., 
2010).  This thesis also highlights the importance of JNK3 in proNGF-treated aged 
SCG neurons cultures.  JNK Inhibitor IX (inhibits JNK2 and JNK3) was more 
effective than JNK Inhibitor VIII (inhibits JNKI and JNK2 more effectively than 
JNK3) in rescuing cultured aged SCG neurons from proNGF-mediated cell death so 
JNK3 is likely to be important in proNGF-mediated signalling in aged neurons. 
Experiments on JNK actions on neurite outgrowth have also been performed but 
largely in neuronal cell lines such as PC12 cells (Heasley et al., 1996).  When 
undertaking research, it is important to note that not all JNK isoforms are expressed 
by these cells.  While JNK1 and 2 have been shown to induce neurite outgrowth, 
JNK3 is not expressed in PC12 cells and requires exogenous transfection to induce 
NGF-induced sprouting (Waetzig and Herdegen 2003b).  In this study, the 
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administration of different isoform-specific JNK inhibitors suggest JNK3 to be a more 
effective regulator than JNK1/2 for neuronal outgrowth of cultured aged SCG 
neurons in the presence of NGF and proNGF.  However, further inhibitor studies are 
required to determine the specificity.  In peripheral axons, JNK3 forms a complex 
with kinesin 1, JIP3 or Syd (a mammalian homolog of JIP3), which mediates the 
axonal transport of JNK by interaction with the dynactin/dynein motor system 
(Cavalli et al., 2005).  Following axotomy of mouse sciatic nerves, JNK3 is activated 
and anterograde transport is disrupted, whereas retrograde transport increases.  It is 
believed that JNK3 acts as a surveillance sensor that responds to stress by altering 
motor transport.  
To complement this study, research into adult DRG found that neuritogenesis is 
delayed by lack of JNK2 and JNK3, but not JNK1 (Barnat et al., 2010).  However, 
Barnat et al. (2010) goes on to show that JNK signalling is further required for 
sustained neurite elongation as pharmalogical pan-JNK inhibition resulted in neurite 
retraction, which relies on JNK1 and 2.  Studies indicate that JNK1 could have a 
fundamental role in elongation by phosphorylating proteins that regulate 
microtubule dynamics, such as MAP1B, MAP2, and stathmin family proteins (Chang 
et al., 2003; Bjorkblom et al., 2005; Tararuk et al., 2006).  This was not investigated in 
this study as JNK inhibitors were administered at the time of plating but there is 
potential for further studies on the impact of JNK inhibition on elongation after 
neurite outgrowth has been initiated.  
 
 
4.1.3 p75NTR adaptor protein NRAGE 
 
Once activated, the p75NTR receptor is dependent on the recruitment of adaptor 
protein complexes for further signalling, due to a lack of intrinsic catalytic activity.  In 
NGF-responsive neurons, the p75NTR/NRAGE interaction is involved in JNK-
mediated apoptosis (Salehi et al., 2000).   
The results in this thesis suggest that NRAGE helps to mediate cell death at all stages 
of life, from early development to ageing.  Significantly, this was the first report of 
NRAGE involvement in neurotrophic signalling of aged SCG neurons and, similar to 
	118		
	
Discussion 
	
	 	
JNK inhibition, NRAGE knockdown only rescued survival during proNGF-induced 
cell death.  Survival of neurons remained unaffected in the presence of NGF.  
It was also revealed that neuritogenesis of aged SCG neurons was unaffected after 
NRAGE knockdown, which supports previous NRAGE knockout studies in mice 
where neuronal growth was unaffected (Bertrand et al., 2008).  This, however, differs 
from results observed in PC12 cells.  Reddy et al, 2010 reported that expressing 
endogenous NRAGE enhanced NGF-dependent neurite outgrowth, while Feng et al., 
2010, found that NGF-mediated outgrowth is accelerated following RNA knockdown 
of NRAGE.  Therefore, although NRAGE has been linked with p75NTR-dependent cell 
cycle arrest in sympathetic neurons (Kendall et al., 2002; Reddy et al., 2010), there is 
still some uncertainty as to the impact of NRAGE on neuritogenesis. 
As NRAGE expression is predominantly confined to neurons (Barrett et al., 2005), 
western blot analysis gives suitable reflection of protein levels in neurons from aged 
tissue samples, which contain a combination of cell types.  Low NRAGE expression is 
found in the adult nervous system, (Salehi et al., 2000; Kendall et al., 2002), and there 
is substantial variation in NRAGE expression levels between individuals, and 
between species in different regions of the adult nervous system (R. Al-Shawi; J.P 
Simons, personal communication).  Previous SCG lysates from individual rats, and 
lysates from pooled mouse SCG in this study, show considerable variation between 
samples.   
In addition, this study observed no significant difference between young adult or 
aged animal samples of pooled sympathetic neurons, when normalised against actin 
expression.  However, studies in the mouse brain revealed that in some regions 
vulnerable to age-related neuronal loss, NRAGE protein expression is elevated on 
ageing, although these samples were taken from individual mice (R. Al-Shawi; J.P 
Simons, personal communication).  In any case, this local and regional variability 
observed between individuals suggests that NRAGE expression is highly plastic in 
the adult nervous system. 
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4.1.4 Glia 
 
More attention is frequently placed on neurons in research, and glial responses have 
not been as thoroughly investigated.  In the PNS, JNKs control cell proliferation and 
death of Schwann cells, and have also been implicated in Schwann cell de-
differentiation during the process of nerve regeneration  (Monje et al., 2010).  A better 
understanding of the delicate mechanisms behind the survival and proliferation in 
glial cells, and the switch into a regenerative state in neurons is an essential part in 
our efforts to improve the outcome of nerve repair, post nerve injury and during 
ageing.  
 
In this study, similar to neurons, JNK inhibitors halted the proliferation of glia 
isolated from the SCGs of aged adult mice.  The growth of glial extensions was also 
restricted to varying degrees depending on the type of inhibitor.  JNK inhibitor IX 
was, again, the most effective inhibitor.  After following the cultures for three days, 
the glia appeared to shrivel up but Live/Dead assays confirmed that glia were still 
alive. 
The association of JNKs in the regulation of proliferative and terminally differentiated 
oligodendrocytes, in cell death and disease also exists in the CNS (Casaccia-Bonnefil 
et al., 1996; Ladiwala et al., 1998; Yoon et al., 1998; Jurewicz et al., 2003; Gadea et al., 
2008) and in response to injury (Gadea et al., 2008).  In most cases, the proliferation or 
hypertrophy of several different types of glial cells, including oligodendrocytes in 
response to injury can lead to abnormal levels of glia resulting in gliosis (Robel et al., 
2011).  In turn, this can be detrimental to nearby neurons.  Glial scar formation due to 
reactive astrogliosis in spinal cord injury can also be detrimental as it forms an 
impenetrable barrier for regenerating axons (Yuan and He 2013).  The results in this 
study may have therapeutic implications in the use of JNK inhibitors for regulating 
and inhibiting these reactions, without killing the glia and surrounding neurons. 
 
It would also be of interest to fully characterise the population and composition of 
specific glia post-injury in adult SCG and during ageing.  As satellite glial cells and 
Schwann cells display different characteristics and possess different biological 
functions, it may be that they respond differently to drug application and this might 
directly or indirectly affect their relationship with neurons. 
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4.1.5 Implications for treatment 
 
Realistically, the only way to currently evaluate the importance of experimental 
findings is to develop, and test, a given treatment in human subjects.  While the 
conversion of experimental findings to the clinic is possible, it is not always a clear-cut 
process.  There are plenty of examples of encouraging preliminary results in animals 
that fail to materialise into clinically effective compounds.   However, assembling 
evidence from clinically relevant studies does have the ability to further support data 
from animal experiments. 
A suggestion for the use of JNK inhibitors during the process of gliosis has already 
been discussed but there may also be implications for neuronal pathologies.  In 
Alzheimer’s disease, retrograde transport of NGF from the cortex and hippocampus 
to basal forebrain cholinergic neurons (BFCN) is reduced as these neurons 
degenerate, with the simultaneous accumulation of proNGF in the cortex and 
hippocampus (Fahnestock et al., 2001; Peng et al., 2004; Pedraza et al., 2005).  
Interestingly, post‐mortem brains from patients with this disease have been shown to 
display distinctly high levels of JNK activity as well (Ferrer et al., 2001).  Although 
studies in AD have primarily focused on the role of JNK in increasing amyloid‐β 
plaque load (Mazzitelli et al., 2011), and hyper-phosphorylated tau (Reynolds et al., 
1997; Reynolds et al., 2000), the relevance of JNK and the association with proNGF-
mediated cell death may be important in this vicinity too. 
JNK1 and JNK3 present distinct subcellular distributions (Lee et al., 1999; Brecht et al., 
2005) (Lee et al., 1999) in areas of the adult mouse brain.  JNK3 is prominent in the 
nuclei of a subset of neurons (~30%) in the cortex and JNK1 expression dominates in 
the somal cytoplasmic space and neurofibres.  In the hippocampus, JNK3 expression 
is found in ~90% of pyramidal layer neurons, whereas JNK1 expression is restricted 
to areas of the dentate gyrus (Lee et al., 1999).  It would certainly warrant further 
investigation to observe whether proNGF-mediated cell death in an AD model is not 
only JNK-dependent, but isoform-specific, and if subcellular distribution has an 
impact on this. 
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4.1.6 Culturing aged neurons 
 
In culture conditions, neurons are taken out of an in vivo environment and placed in 
an artificial one.  The administration of collagenase and trypsin, and the process of 
trituration isolates the neurons, strips them from cell adhesion molecules and places 
them under a considerable amount of stress.  It is inevitable that they seek to enter a 
state of regeneration once placed in growing conditions.  In this study, it appears that 
aged neurons are more robust than neonatal neurons.  In fact, aged and young adult 
neuronal cultures were able to last for three days without changing the medium.  
Because of this, cells could be followed for a number of days to observe the 
development of various signalling pathways.  An interesting observation was the 
breakdown of neuronal cultures, sometimes by Day 3, after a high percentage of 
initial neurite outgrowth. This was taken into account during analysis but something 
to keep in mind for further experimentation.  Although refreshing the medium would 
mean the disturbance of aged neurons, their robust nature might allow them to 
withstand this disruption and help cultures thrive longer than we initially envisaged.  
On the whole, this study validates previous experiments used for culturing aged 
neurons (Orike et al., 2001a; Al-Shawi et al., 2008), and provides further evidence of a 
reliable model for research of aged sympathetic neurons. 
 
It also provides a suitable model to investigate pro-regenerative responses in ageing, 
something that has traditionally been examined in vivo, following conditioning lesions 
or drug application, mostly in the DRG and sciatic nerve of young adult rodents 
(McQuarrie and Grafstein 1973; Kilmer and Carlsen 1984; Smith and Skene 1997; 
Neumann et al., 2002; Qiu et al., 2002).  As discussed in the General Introduction, 
only recently has it been established that axotomy of peripheral sensory neurons 
(DRG), by dissociating and culturing them, prompts a similar response to in vivo 
conditioning lesions. The activation of injury-associated transcription factors and up-
regulation of regeneration-associated genes (Smith and Skene 1997; Saijilafu et al., 
2013), followed by the characteristic neurite regrowth patterns occur within the first 
24 hours of culture (Frey et al., 2015).  Supplementary to the work described in this 
thesis, Frey et al. (2015) continued to demonstrate that stimulation of the pro-
regenerative state in vitro requires JNK signaling, a key factor within the pro-
regeneration response in vivo.  The group also identified an in vitro platform to induce 
a pro-regenerative state, in the absence of injury, by guiding neurons into a 
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‘’functionally naïve’’ state.  Thus creating an assay capable of selectively identifying 
drugs that induce the pro-regenerative state, rather than directly modulating neurite 
extension.   
 
Understanding the mechanisms responsible for inducing the pro-regenerative 
program could have important consequences for axon regeneration in ageing and a 
variety of neurological disorders.  Based on the results of this study, the use of JNK 
inhibitors to assist with peripheral nerve regeneration would perhaps not be advised.  
However, there is potential for transferring the Frey et al. (2015) model to aged 
sympathetic neurons and administering JNK inhibitors to more closely identify the 
role of different isoforms in an enhanced pro-regenerative state similar to in vivo.  It 
would also help to complement the search for more specialised JNK inhibitors that 
replicate actions in vivo.  
 
4.1.7 Future Directions 
 
Despite the suggestions above, the benefits of acquiring in vivo information on the 
influence of JNK post injury and during ageing, in sympathetic neurons, must not be 
forgotten.  Reviews by Bogoyevitch et al. (2010) and Coffey et al. (2014) give detailed 
accounts of JNK KO studies to date.  From the evidence provided, the oldest model 
previously used for JNK knockout studies are 8-month old mice (Chen et al., 2001; 
Chang et al., 2003).  Chang et al., used Jnk1-/- KOs to observe the impact on the 
structural maintenance of microtubules in the spinal cord and hippocampus, while 
Chen discovered an effect of Jnk2-/- KOs on skin tumorogenesis. 
The lack of JNK knockout studies in ageing research may be attributed to earlier 
fatalities or the costs of breeding animals for extended periods.  While there is limited 
data on aged rodent knockouts, there is plenty of information during early 
development and to a lesser extent, in adults.  Only compound mutants lacking Jnk1 
and Jnk2 genes together were embryonically lethal (Kuan et al., 1999) suggesting that 
there is adequate scope for other JNK isoform knockout studies.  Furthermore, JNK 
studies in the context of axotomy and regeneration are also deficient beyond the 
regenerative role of c-Jun, in the adult rat, following facial nerve fibre cut (Ruff et al., 
2012).  So, an important extension of the work described in this thesis would be to 
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implement these in vivo JNK knockout models in aged rodents, and post injury, to 
complement results from cell culture methods.  Inducible methods would be 
especially useful to differentiate between developmental and ageing effects. 
 
Ultimately, there is still a huge cloud over the outcome of neurotrophic signalling in 
ageing, and after injury.  The dichotomy of neuritogenesis and cell death quite clearly 
exists and vital factors along the chain perfectly symbolise this.  Although it is 
necessary to fully characterise which activators and effectors steer JNK signalling in a 
particular direction, other key players require attention.  
 
4.1.8 Future areas of study and new emerging therapies 
 
In recent years, studies have indicated that the p75NTR signalling receptor is part of a 
regulatory program to remove defective neurons and axons post injury and during 
degeneration in adults, with a propensity to worsen the damage by the formation of 
severe lesions.  As a result, small p75NTR-binding peptides (Longo et al., 1997) and 
organic compounds (Massa et al., 2006) have been generated to counteract this.  
Ibanez and Simi (2012) give a good account of these, as well as the expression and 
functional consequence of p75NTR signalling after neural injury, and cellular stress.  
Although p75NTR has been shown to promote cell-death, it also has to ability to 
influence cell survival (Introduction).   
A suggested role for NRAGE and other p75NTR interacting proteins as future drug 
targets, certainly in p75NTR/JNK-mediated apoptosis, has increased their value in 
ongoing research.  However, information on the changes in the expression of other 
p75NTR interacting proteins e.g. NRIF, is still lacking during ageing.  In neuritogenesis,  
the question of which scaffold proteins are also involved requires further clarity. 
Previous findings suggest the possible involvement of JIP-1 and JIP3 in the 
organisation of JNK-mediated microtubule dynamics underlying neurite outgrowth 
but studies have been limited to PC12 cells (Meyer et al., 1999; Sato et al., 2004). 
While results displayed the involvement of JNK in proNGF-mediated cell death and 
neuritogenesis, further studies would help to confirm how this arises further 
downstream.  The expression of transcription factors, such as c-Jun, activator protein 
1 (AP-1) and other downstream targets are also important regulators of signalling 
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pathways e.g. c-Jun, which is involved in a myriad of responses such as 
neuritogenesis, regeneration and axotomy-induced death in the adult nervous system, 
and is not just phosphorylated by JNK thus adding to the complexity of the system 
Another inviting direction for prospective research is to delve deeper into the impact 
of subcellular localisation of specific JNK isoforms.  A report by Bjorkblom et al., 
(2008) in the brain challenged the idea that inhibition of a single JNK isoform (for 
example, JNK3) provides neuroprotection in adults and older subjects and suggested 
that subcellular compartment-specific targeting was more effective.   
 
It was previously reported in cerebellar granule neurons, that while JNK1 is present 
mainly in the cytoplasm of neuronal processes, JNK2 and JNK3 can be translocated to 
the nucleus and affect transcription of regeneration-associated genes e.g. c-Jun 
(Coffey et al., 2002).  With this in mind, targeted inhibitors of JNK were created, by 
fusing a nuclear export sequence (NES) or a nuclear localisation sequence (NLS) 
upstream of the JNK inhibitor JBD resulting in constructs with selectivity of action in 
the cytosol and nucleus (Bjorkblom et al., 2005; Tararuk et al., 2006).  Constructs 
expressed in cerebellar granule neurons of neonatal rats, with selectivity of JNK 
inhibition in the cytosol, imitates the Jnk1 KO study (Coffey et al., 2002) by causing 
radial migration in the developing brain and a reduction in neurite growth.  By 
contrast, nucleus selective JNK inhibitor constructs do not disrupt these physiological 
events (Bjorkblom et al., 2005; Tararuk et al., 2006) but they do provide substantial 
protection from p75NTR induced neuronal death in response to trophic support 
withdrawal (Bjorkblom et al., 2008).  This is supported by recent studies in HEK293 
cells where JNK activity prevents p75NTR receptor cell death signalling in the nucleus 
but not the cytoplasm (Charalampopoulos et al., 2012).  Essentially, the report 
demonstrates the importance of nuclear JNK for signalling death and cytoplasmic 
JNK for neurite outgrowth. 
 
Specific inhibition of JNK in mitochondria is another successful targeting approach.  
An enrichment of JNK in the mitochondria is visible following excitotoxic stresses e.g. 
transient middle cerebral artery occlusion and kainate treatment in the brain (Zhao 
and Herdegen 2009).  A peptide developed by Chambers et al., (2011) which blocks 
JNK recruitment to mitochondria, reduces ischemic damage in neonatal rats (Nijboer 
et al., 2013).  Further information on drug therapy and compartment‐specific 
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targeting of JNK to block pro‐apoptotic JNK action has been reviewed by Coffey 
(2014).  The possibility for organelle targeting by peptide drugs has certainly 
unraveled a promising therapeutic strategy (Graczyk 2013).  It is definitely an area 
that would help to complement the work in this thesis and in existing and current 
literature. 
 
4.1.9 Closing remarks  
 
Throughout life, cells are differentially regulated depending on their requirement at 
different stages of development, maturation and regeneration.  Environmental cues, 
receptor complement expression and the complex temporal and spatial regulation of 
relevant ligands and intracellular signalling proteins all contribute to the desired 
signalling outcome.  Quite clearly, there are a number of factors at work during the 
process of ageing and we are far from predicting the final outcome of signalling 
pathways because of increased variability.  However, a better grasp of the 
components and the machinery that make up these molecular pathways will serve to 
enhance our understanding and also help to provide better strategies for the effective 
treatment of neurodegeneration. 
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